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Health-related consequences 
of problem alcohol use 
On 1 November the Alcohol and Drug 
Research Unit of the Health Research Board 
published Overview 6, Health-related 
consequences of problem alcohol use.1 The 
purpose of this Overview was to compile 
and analyse the available data on problem 
alcohol use in Ireland and its health-related 
consequences. It is hoped that this will help 
determine what approaches are likely to be 
effective in reducing alcohol-related harm, 
and identify gaps in current knowledge so as 
to inform future research needs in this area. 
Ireland has one of the highest levels of 
alcohol consumption in the European Union. 
In 2006, the average rate of consumption 
of pure alcohol per adult (aged 15 years or 
over) was 13.36 litres. This compares to a 
rate of 11.38 litres in 1995 and represents 
an increase of 17%. Alcohol consumption 
increased steadily between 1995 and 2001, 
when it peaked at 14.3 litres per person. The 
fi rst notable decrease occurred in 2003, when 
consumption decreased by 6%, which is 
widely attributed to the increase in excise duty 
on spirits in the 2002 budget. Since 2003, the level of alcohol consumption has remained static. 
As well as being among the highest alcohol consumers in Europe, people in Ireland engage in 
drinking patterns that are excessive and problematic, with heavy and binge drinking now the norm 
for a substantial number of people. A number of population studies have confi rmed this, both in 
adults and in young people. 
In order to study alcohol-related harm in Ireland, data from the Hospital In-Patient Enquiry (HIPE) 
scheme, maintained by the Economic and Social Research Institute (ESRI), and from the General 
Mortality Register (GMR), maintained by the Central Statistics Offi ce (CSO), were analysed for the 
years 1995–2004. Alcohol treatment in Ireland was analysed using data from the National Drug 
Treatment Reporting System (NDTRS) and the National Psychiatric In-Patient Reporting System 
(NPIRS), both of which are maintained by the Health Research Board. 
According to the HIPE data, there were 139,962 alcohol-related discharges n the 10 years between 
1995 and 2004. Annual fi gures rose from 9,254 in 1995 to 17,378 in 2004. People with alcohol-
related illness used 117,373 bed days in hospitals in 2004, accounting for 2.9% of all bed days that 
year, compared to 55,805 bed days in 1995. 
Men accounted for 75% of the cases discharged from hospital and women accounted for 25%. 
Discharges peaked in the 50–59 age range. Over 26,000 discharges were aged 30 or under. Four 
out of fi ve of this group had acute problems, but over 5,000 had chronic conditions or alcohol-
related liver disease. This is extremely worrying, given that it takes a number of years of hazardous 
drinking to develop chronic conditions.
The results also highlight some serious implications for women’s health. The age profi le of the 
women discharged from hospital was much lower than that of the men. While women accounted 
Dr Deirdre Mongan, author of Health-
related consequences of problem alcohol use, 
at a media briefi ng on the report in the 
HRB. (Photo: JJ Berkeley)
Annual report 
2007: the state of 
the drugs problem 
in Europe
was published by the 
European Monitoring 
Centre for Drugs and 
Drug Addiction on 22 
November 2007.
Topics of interest in the 
report include the rise 
in cocaine use, drug use 
among under-15s, and 
drugs and driving.
This report is covered on 
p. 18 of this issue.
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for just 25% of all discharges in the 10-year 
period, in 2004 they accounted for 47% of 
discharges under the age of 18. This is not 
surprising as a number of studies have indicated 
that alcohol consumption has increased 
substantially among young girls since 1995. 
If alcohol consumption among young Irish 
women continues to follow current trends, it is 
likely that the number of middle-aged women 
experiencing alcohol-related morbidity will 
increase in the future. 
A total of 1,775 people died from alcohol-
related causes between 1995 and 2004, with 
men twice as likely to die from an alcohol-
related cause. A total of 68% of these deaths 
were in people aged 60 or under. To put this in 
perspective, only 21% of deaths in the general 
population in this period were under 65 years of 
age, highlighting the increased risk of premature 
death associated with alcohol use.
During 2005, 5,527 people received treatment 
for problem alcohol use, according to the 
NDTRS, and 2,995 people were admitted to 
psychiatric units for alcohol-related illness, 
according to the NPIRS. Data from the NDTRS 
reveal that 2,827 people entered treatment for 
the fi rst time in 2005. However, as coverage for 
alcohol treatment agencies is still incomplete, 
it can be reliably assumed that the number 
presenting for treatment is actually much 
higher. Treatment fi gures also show that one in 
fi ve people receiving treatment for alcohol are 
using at least one other drug. This is increasingly 
common among young people, with 8% of 
people treated for use of more than one drug 
aged 17 or under, compared to 1.6% of the 
same group treated for alcohol only.
This Overview emphasises the need to reduce 
alcohol consumption in Ireland. There is a 
clear link between levels of consumption and 
alcohol-related harm. For example, the two 
years of highest consumption – 2001 and 
2002 – coincide with the highest numbers 
of deaths and discharges; and in 2003, the 
fi rst decrease (of 6%) in consumption also 
coincides with the fi rst decrease (of 2%) 
in alcohol-related discharges. International 
evidence supports alcohol taxation, regulating 
the physical availability of alcohol and drink-
driving countermeasures as effective strategies 
for reducing alcohol consumption and related 
harm. 
This Overview also highlights the need for 
accurate and complete data on those receiving 
treatment as well as greater integration of 
alcohol and drug services, given the high 
level of polydrug use. There is also a need to 
identify those with hazardous drinking patterns 
in a variety of settings before they begin to 
experience alcohol-related harm. 
(Deirdre Mongan)
1. Mongan D, Reynolds S, Fanagan S and 
Long J (2007) Health-related consequences 
of problem alcohol use. Overview 6. Dublin: 
Health Research Board.
Alcohol consumption in Ireland
The recently published report, Alcohol 
consumption in Ireland 1986–2006,1 written by 
Dr Anne Hope for the Health Service Executive 
– Alcohol Implementation Group, explains how 
alcohol consumption in Ireland is measured and 
describes trends in consumption since 1986. 
Alcohol consumption is measured by dividing 
the total alcohol sales fi gures provided by the 
Revenue Commissioners by the population 
fi gures provided by the Central Statistics Offi ce 
(CSO). The Revenue Commissioners compile 
annual alcohol sales fi gures based on the 
volume of each alcoholic beverage type (beer, 
spirits, wine and cider) released from bonded 
warehousing on payment of excise duty. The 
fi gures for beer and spirits are given in litres 
of pure alcohol. Figures for wine and cider are 
given by total volume, and the pure alcohol 
content is calculated based on an ABV (alcohol 
by volume) rate of 12.5% in the case of wine 
and 4.5% in the case of cider.
Consumption of alcohol per capita and per 
adult in the total population is calculated 
using the total sales fi gure for pure alcohol as 
outlined above and dividing it by the population 
fi gures provided by the CSO. Given that 21% 
of the Irish population is aged under 15 years, 
it is generally considered that the rate of 
consumption of pure alcohol per adult (aged 15 
years or over) is a more accurate refl ection of 
consumption at a population level than the per 
capita rate. Since 1986 there has been a gradual 
increase in the proportion of adults in the 
population, which is an important factor when 
interpreting alcohol consumption fi gures and 
comparing consumption trends over time.
Alcohol consumption per adult increased from 
9.8 litres of pure alcohol in 1987 to a peak of 
14.3 litres in 2001, an increase of 46%. The 
period of most rapid increase was from the 
mid-1990s to 2001 (Figure 1). Consumption 
decreased by 6% between 2002 and 2003. 
From 2004 onwards, consumption levels 
have remained quite static. Beer is the most 
widely consumed alcoholic beverage in 
Ireland and accounted for 6.82 litres of pure 
alcohol per adult in 2006, which is similar to 
the level consumed in 1986 (6.93 litres). Beer 
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3consumption peaked in 1998, when 8.33 litres 
of pure alcohol per adult was consumed as beer. 
Since then, beer consumption has been decreasing. 
Other noticeable trends in the type of drink 
consumed include the rise in popularity of wine, 
with an increase of 363% between 1986 and 2006, 
from 0.62 to 2.87 litres per adult. The consumption 
of spirits increased steadily between 1995 and 
2002 (up 42%) but decreased by 21% in 2003 
following an increase in excise duty. A similar trend 
is noticeable for cider, with consumption increasing 
by 515% between 1986 and 2001, from 0.20 to 
1.23 litres per adult. An increase in excise duty in 
December 2001 resulted in a 13% reduction in 
cider consumption in 2002. In 2004, for the fi rst 
time, consumption of wine exceeded that of spirits. 
Beer still has the largest market share of any 
alcoholic beverage, although its consumption is 
decreasing and its market share fell from 69% in 
1986 to 51% in 2006 (Table 1). Wine has shown 
the greatest increase in popularity in the past 20 
years, from 6% to 21%, and now has a higher 
market share than spirits. The market share of cider 
has also increased, from 2% in 1986 to 8% in 2006. 
While alcohol consumption decreased from a 
peak of 14.3 litres of pure alcohol per adult in 
2001 to 13.3 in 2006, Ireland remains among the 
top alcohol-consuming countries in Europe, after 
Luxembourg and Hungary. In 2003, the average 
consumption per adult in the enlarged European 
Union was 10.2 litres, compared to 13.4 litres in 
Ireland. 
This report demonstrates that alcohol consumption 
has increased substantially in the past 20 years and 
Ireland now consumes more alcohol per adult than 
most of its European counterparts. There has also 
been considerable change in the choice of beverage 
consumed, with beer declining in popularity and 
wine and cider showing considerable increases in 
market share. 
(Deirdre Mongan) 
1. Hope A (2007) Alcohol consumption in Ireland 
1986–2006. Report for the Health Service 
Executive – Alcohol Implementation Group. 
Dublin: Health Service Executive.
Litres of pure 
alcohol per adult
1986 1991 1996 2001 2006
10.1 10.9 12.1 14.3 13.3
Market share % % % % %
Beer 69 69 65 55 51
Spirits 23 21 19 21 19
Wine 6 7 10 14 21
Cider 2 3 6 9 8
Figure 1 Alcohol consumption per adult by beverage type, 1986–2006 
Source: Revenue Commissioners and CSO annual reports
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Alcohol consumption in Ireland (continued)
Table 1  Consumption of alcohol by market share of each beverage, 1986–2006
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4Voluntary alcohol advertising codes still 
on probation
In July 2007 the Alcohol Marketing Communications 
Monitoring Body submitted to the Minister for Health its 
fi rst annual report on the implementation of and adherence 
to the voluntary codes of alcohol advertising.1 Drawn up 
by the Drinks Industry Group of Ireland, the Association of 
Advertisers in Ireland and representatives of the media, the 
codes are intended to limit the exposure of under-18s to 
alcoholic drink advertising.2
During 2006 the Monitoring Body found there was overall 
compliance with the voluntary codes. Where identifi ed 
breaches had occurred, the Body was generally satisfi ed that 
immediate remedial action had been taken and measures 
introduced to prevent a recurrence. However, the Body 
called on the media partners to put procedures in place to 
prevent breaches occurring in the fi rst place.
The Monitoring Body made the following recommendations:
Television: Broadcasters should be careful when scheduling  ■
alcohol advertising during school mid-term breaks and 
holidays, and during certain sporting events, such as the 
2006 World Cup, as it is possible that higher than normal 
numbers of young people might be watching.
Cinema: Consideration should be given to the practice of  ■
placing an advertisement for alcohol outside of the main 
advertising reel, after the fi lm certifi cation information 
and before the start of the fi lm.
Radio: The Independent Broadcasters of Ireland (IBI)  ■
should be encouraged to develop the Code of Conduct 
for Presenters, which should be applicable to all member 
stations.
General: The media partners might wish to examine the  ■
issue of electronic media, which is not covered under the 
current Codes.
The Minister of State at the Department of Health, Pat the 
Cope Gallagher TD, has outlined the government’s response 
to the Monitoring Body’s report:
Following consideration of the Report my Department 
has decided to commence discussions with the 
relevant stakeholders with a view to strengthening 
and expanding the current voluntary codes on alcohol 
marketing and communications in order to provide 
signifi cantly greater protection for children and young 
‘No safe level of alcohol consumption 
during pregnancy’
On 7 September 2007, Mr Pat the Cope Gallagher TD, 
Minister for Health Promotion and Food Safety, highlighted 
the risk of alcohol consumption in pregnancy. Minister 
Gallagher stated: ‘I wish to endorse the advice being given 
today by the Department of Health and Children’s Chief 
Medical Offi cer. It is essential that women are provided 
with all the relevant information for a safe and successful 
pregnancy. Therefore, women need to be aware of the risk 
associated with alcohol consumption during pregnancy. 
As the evidence does not specify a safe level of alcohol 
consumption, the best advice to women is not to consume 
alcohol if pregnant or trying to conceive.’1
The minister’s statement follows the publication of a report 
earlier this year entitled The Coombe Women’s Hospital 
study of alcohol, smoking and illicit drug use, 1988–20052, 
which found that most pregnant women drink alcohol, 
with one in 10 drinking more than six units per week, a 
pattern more pronounced in younger women. Following 
this publication, Mary Harney TD, Minister for Health and 
Children, asked the Chief Medical Offi cer (CMO) to consider 
the data presented in the study. The CMO also reviewed 
the available international evidence, including that from the 
Surgeon General in the US and the Department of Health in 
the UK.
The CMO has concluded that ‘there is no safe level of 
alcohol consumption during pregnancy’, and has given 
unambiguous advice on the matter, stating: ‘Given the 
harmful drinking patterns in Ireland and the propensity 
to “binge drink”, there is a substantial risk of neurological 
damage to the foetus resulting in Foetal Alcohol Spectrum 
Disorders (FASD). Alcohol offers no benefi ts to pregnancy 
outcomes. Therefore, it is in the child’s best interest for a 
pregnant woman not to drink alcohol during pregnancy.’ 
The Health Service Executive (HSE) will commence work 
on updating information material for use by the general 
public and medical professionals to include the CMO’s 
advice that women should avoid alcohol before and during 
pregnancy and while breastfeeding. The HSE will also meet 
with relevant stakeholders with regard to developing and 
implementing education initiatives on this issue for health 
professionals. The Department of Health and Children 
is consulting with relevant stakeholders on the proposal 
to introduce a requirement that alcohol containers and 
promotional material carry a health warning about drinking 
alcohol during pregnancy. 
(Deirdre Mongan)
Department of Health and Children (2007) Minister 1. 
Gallagher renews advice to women not to drink 
alcohol in pregnancy. Press release, 7 September. 
Retrieved 12/09/2007 from http://www.dohc.ie/press/
releases/2007/20070907.html.
Barry S, Kearney A, Lawlor E, McNamee E and Barry J 2. 
(2006) The Coombe Women’s Hospital study of alcohol, 
smoking and illicit drug use, 1988–2005. Dublin: Coombe 
Women’s Hospital. 
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drug use in Ireland: an overview
A new research report examining the association between 
aspects of social exclusion, problematic drug use and social 
reintegration as a response to this type of drug use in Ireland 
was launched on 6 November by the Alcohol and Drug 
Research Unit (ADRU) of the Health Research Board (HRB).1 
Social exclusion, in the form of homelessness and 
insecure accommodation, inadequate education and poor 
employment skills, is closely associated with problematic 
drug use. As a response, social reintegration has emerged as 
a key aspect of drug treatment and rehabilitation in order 
to provide responses to accommodation, education, and 
vocational training and employment support requirements 
of problem drug users. 
Social reintegration of problematic users is not a new 
concept; indeed, it has been around since the early 1960s.2 
The fi rst attempt to include social reintegration measures in 
Irish drug policy occurred in the 1971 Report of the working 
party on drug abuse.3 Subsequent drug policy development 
in 1991, 1996 and 2001 emphasised the importance of 
linking vocational training and employment skills with 
drug treatment.4-6 Since 2000, the Council of the European 
Union has urged member states to improve availability of, 
and access to, social reintegration services for drug users, 
and the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) and National Focal Points (NFPs) have 
been asked to monitor and report on the accessibility and 
availability of such measures in members states throughout 
the EU.7,8
This Overview brings together information on the 
association between unemployment, homelessness and 
problem drug use in Ireland and examines how drug 
policy and practice have responded to this situation. This 
information comes from in-depth interviews with service 
providers, an exploration of research and evaluation and 
policy documents and an analysis of data from the National 
Drug Treatment Reporting System (NDTRS). The main 
fi ndings from an extensive literature search indicate that 
failure to address unemployment and homelessness among 
drug users can undermine treatment gains and lead to 
social exclusion.
Early chapters include an executive summary and details of 
the background and structure of the report and the data 
sources used. Chapter three presents the background to 
the development of social reintegration as a concept and 
examines the extent to which drug policy and practice 
in Ireland have understood the concept. Despite policy 
proposals to improve educational levels and employability 
among drug users in Ireland since the early 1970s, in 
practice, social reintegration measures have developed 
unevenly and at a much reduced rate, compared to drug 
prevention and treatment services. Consequently, there is 
a clear need to extend the discourse of drug responses to 
include social reintegration.
Chapter four examines the employment status of 
problematic drug users in Ireland, how drug users perceive 
employment and the barriers they experience when trying 
to improve their chances of fi nding employment. The key 
fi ndings to emerge include the following:
Of cases commencing treatment for problematic  ■
drug use in Ireland in 2003, just under 20% were in 
employment, compared to the national average of 65%, 
and 61% were unemployed, compared to the national 
average of 4.6%. 
Drug users who are employed use their main problem  ■
drug less frequently and report better drug treatment 
outcomes than their unemployed counterparts. 
people. I will give further consideration to the possibility 
of using legislation in this area depending on the 
outcome of these discussions.3 
(Brigid Pike)
1. Alcohol Marketing Communications Monitoring Body 
(2007) Limiting the exposure of young people to alcohol 
advertising. First annual report 2006. Retrieved 29 
November 2007 from www.dohc.ie 
2. For an account of the establishment and purpose of the 
Monitoring Body, see Pike B (2006) Self-regulation of 
alcohol advertising is on probation. Drugnet Ireland 
17: 6.
3. Gallagher P the Cope (2007, 21 November) 
Parliamentary Debates Dáil Éireann Offi cial Report: 
Unrevised. Vol. 642, col. 234, PDF version. Available at 
www.gov.ie/oireachtas/frame.htm
Alcohol advertising codes (continued)
Mr Martin Keane, author of Social reintegration as a 
response to drug use in Ireland. (Photo:  JJ Berkeley)
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6Drug users view employment as an important part of  ■
recovery and do not see methadone maintenance as a 
barrier to being employed. 
Homelessness and drug use are strong indicators of social 
exclusion. Chapter fi ve presents research from Ireland that 
shows the levels of social exclusion experienced by homeless 
drug users. For example: 
In 2003 almost 7% of drug users entering treatment in  ■
Ireland were homeless. 
When drug users are homeless they are likely to  ■
increase their drug use and progress to patterns of 
chaotic drug misuse. 
Homeless drug users associate their experiences of  ■
emergency hostel accommodation with their more 
chaotic periods of drug use. They have poorer physical 
and mental health than homeless people who do not 
use drugs.
Policy and practice have often been slow in the past to 
respond to the accommodation needs of homeless drug 
users. Chapter six presents examples of recent shifts in policy 
and practice on drugs and homelessness which suggest that 
the situation is improving. For example, the National Drugs 
Strategy6 recognises that the provision of accommodation 
is an integral element of drug treatment and the 2006 
homeless preventative strategy9 calls on all agencies working 
on behalf of drug users to work together to improve services. 
Vocational rehabilitation is about developing the personal 
competencies and improving the employability of the 
recovering drug user. Chapter seven presents the theory 
behind vocational rehabilitation and chapter eight presents 
the evidence to show that treatment outcomes can be 
improved when clients are assisted in developing their 
vocational skills. 
Evidence suggests that vocational training contributes to  ■
a reduction in drug use. 
Completion of vocational programmes is strongly  ■
associated with obtaining employment and improved 
personal and social functioning.
Supported work interventions and dedicated  ■
employment counsellors are effective at getting drug 
users into employment.
Evidence from vocational rehabilitation interventions  ■
in Ireland suggest that participants have made 
educational and vocational progress by improving their 
literacy, achieving accredited training certifi cates and 
progressing to work placement and, in some cases, paid 
employment.
Chapter nine develops the concept of employability and 
provides a framework for service providers to map the 
progression of clients in vocational training projects. 
The main themes to emerge indicate that enhancing 
employability involves matching the attitudes and 
capabilities of the individual, the needs and expectations 
of employers and the demands of the labour market. 
Enhancing employability for drug users also requires an 
inter-sectoral partnership approach from service providers, 
and problematic drug use needs to be brought under 
control through treatment if recovering drug users are to 
have a realistic chance of enhancing their employability.
Finally, chapter ten presents a model of social reintegration 
that predicts the different phases of recovery that drug 
users can experience. The model developed by Buchanan10 
outlines six phases to social reintegration for problem 
drug users. The fi rst four phases signal changes in the 
individual and in their use of drugs as they move from 
chaos to eventual control. The later three phases suggest 
that, while recovering drug user’s move towards ‘normal 
living’, individuals and agencies in the wider society need 
to change their attitudes and behaviour towards recovering 
problematic drug users. The model provides a useful 
framework to conceptualise the symbiotic changes that must 
take place on the part of the drug user and the wider society, 
if the vision of social reintegration is to be realised. 
The publication of this Overview is timely in that it follows 
the recently launched report of the Working Group on 
Drugs Rehabilitation.11 That report sets out the structural 
arrangements required to respond to homelessness, 
inadequate education and poor employment skills among 
current, stabilised and former users. It is hoped that the 
evidence presented in this Overview on both the social 
risks of homelessness and unemployment and the ways in 
which these risks can be reduced will help to inform the 
implementation of the rehabilitation strategy. 
(Martin Keane)
1. Keane M (2007) Social reintegration as a response to 
drug use in Ireland. Overview 5. Dublin: Health Research 
Board.
2. United Nations Single Convention on Narcotic Drugs, 
1961 (Article 38, sections 1 and 2).
3. Working Party on Drug Abuse (1971) Report of the 
working party on drug abuse. Dublin: Stationery Offi ce.
4. Department of Health (1991) Government strategy to 
prevent drug misuse. Dublin: Department of Health.
5. Ministerial Task Force on Measures to Reduce the 
Demand for Drugs (1996) First report of the ministerial 
task force on measures to reduce the demand for drugs. 
Dublin: Stationery Offi ce.
6. Department of Tourism, Sport and Recreation (2001) 
Building on experience: National Drugs Strategy 
2001–2008. Dublin: Stationery Offi ce.
7. Council of the European Union (2000) EU Action Plan 
on Drugs 2000–2004. Brussels: Council of the European 
Union.
8. The Alcohol and Drug Research Unit (ADRU) is the Irish 
Focal Point and reports annually, to the EMCDDA on the 
drug situation in Ireland.
9. Pillinger J (2006) Preventing homelessness: a 
comprehensive preventative strategy to prevent 
homelessness in Dublin, 2005–2010. Dublin: Homeless 
Agency.
10. Buchanan J (2004) Missing links? Problem drug use and 
social exclusion. Probation Journal, 51(4): 387–397.
11. Working Group on Drugs Rehabilitation (2007) National 
Drugs Strategy 2001–2008: rehabilitation. Report of 
the working group on drugs rehabilitation. Dublin: 
Department of Community, Rural and Gaeltacht Affairs.
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for methadone-maintained clients
The Report of the Working Group on Drugs 
Rehabilitation1 which was compiled to form the 
basis of the proposed rehabilitation pillar of 
the National Drugs Strategy recommends that 
measures to improve the employability of current, 
former and recovering drug users should form a key 
part of rehabilitation care plans, with the overall 
aim ‘to maximise the quality of life, re-engagement 
in independent living and employability of the 
recovering problem drug user, in line with their 
aspirations’ (p. 21).
The logic of this aspiration to improve employment 
prospects for individuals affected by the use of 
drugs is supported by research from the US by 
Platt,2 which found that clients in employment 
stayed in treatment longer and achieved better 
outcomes than their unemployed counterparts. 
However, with unemployment rates among 
treatment contacts remaining high (61% of 
cases entering treatment in 2003 in Ireland 
were unemployed3), fi nding ways to improve 
employment opportunities is a challenge for service 
providers. 
There is no vocational intervention or programme 
that has been generally adopted for any client 
population or treatment modality in the addiction 
fi eld, although some initiatives have been tried, 
primarily in the US. One such intervention is 
the Customized Employment Supports (CES) 
model. This model is a manual-based, theory-
driven approach and involves a skilled vocational 
counsellor working intensively with a small 
caseload of clients to overcome the vocational 
and non-vocational barriers to employment. The 
model comprises individual counselling, rapid job 
searching and therapeutic fi eldwork. 
A recent evaluation of this model suggests that 
it can be an effective approach to improving the 
employment prospects of methadone clients.4 
This study tested the hypothesis that methadone-
maintained clients assigned to the experimental 
(CES) group would have better employment 
outcomes than those assigned to a control 
condition who received standard vocational 
counselling. The study involved 184 clients at two 
methadone clinics in New York City. Unemployed 
or underemployed clients who were stablised 
on methadone for at least 30 days and who had 
negative urine tests for heroin and/or cocaine use in 
the previous four weeks were eligible to take part in 
the study. Also, an absence of severe mental illness 
or disability and a willingness to enter the study 
were required. 
Participants were randomly assigned to the CES 
group or the control group. The research team 
implemented quality assurance procedures to 
ensure consistency in the way CES counsellors 
delivered the intervention and in the way 
researchers conducted interviews and recorded the 
data from participants. 
Data were collected at baseline and at 6-month and 
12-month follow-ups in interviews with participants 
and from vocational activities logs provided by 
counsellors and documentation of employment 
activity. The retention rate at 12-month follow-up 
was 91% (168/184). The fi nal analytical sample 
comprised 168 participants, of whom 78 were in 
the CES group and 90 in the control group.
The results supported the hypothesis that those 
in the CES group were signifi cantly more likely 
than those in the control group to obtain any 
paid employment and informal, ‘of the books’ 
employment. However, no signifi cant differences 
for competitive employment or total earnings 
were observed between the groups. Competitive 
employment was defi ned as full-time work in 
the labour market, and any paid employment 
meant part-time and temporary jobs. Informal 
employment included jobs that were ‘of the 
books’ and operated in what may be termed the 
‘black economy’, where clients did not pay tax or 
qualify for employment-related protections such as 
pension, annual leave or insurance. 
The authors of the study put forward a number of 
reasons why outcomes for competitive employment 
were not better. These included: 
Clients’ reluctance to seek or accept full-time 
paid employment as this would mean entering a 
competitive labour market, probably at the rate of 
minimum wage because of their poor employment 
histories and lack of skills, with the threat to 
their eligibility for welfare assistance plus rent 
supplement, food stamps and medical insurance if 
they did not succeed in maintaining competitive 
employment 
Clients’ fear at leaving a familiar but  ■
unproductive lifestyle and entering the 
competitive world of work where they would be 
compared with employees of 
long-standing in the labour market 
Client’s preference for temporary or ‘of the  ■
books’ employment as a way of increasing their 
ability 
and confi dence to eventually enter the 
competitive 
labour market 
A deteriorating job-market during the study  ■
period. 
Although this study involved relatively small 
numbers of methadone-maintained clients and the 
transferability of fi ndings from the US to Europe 
is not proven, the fi ndings suggest that intensive 
vocational intervention during treatment can 
improve employment outcomes. 
Finally, in discussing the fi ndings of this study 
and possible implications for policy and practice, 
the authors make a number of pertinent points 
that require further refl ection by all stakeholders 
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reintegration of drug users. 
There is a need for skilled vocational  ■
counsellors, located in or near treatment 
centres, to engage and motivate clients to 
improve their employability.
For such interventions to be more widely  ■
adopted there has to be a strong belief in 
the value of client employment among all 
treatment staff.
Each job taken on by recovering drug users, no  ■
matter how brief, must be valued as a positive 
learning experience for the client.
There is a need for research that follows  ■
employed substance users over considerable 
periods of time to determine how much 
support they need, and for how long.
Progressive social policies that promote 
appropriate incentives for prospective 
employers to encourage them to hire persons in 
recovery need to be developed. 
(Martin Keane)
1. Working Group on Drugs Rehabilitation 
(2007) National Drugs Strategy 2001–2008: 
Rehabilitation. Report of the working group on 
drugs rehabilitation. Dublin: Department of 
Community, Rural and Gealtacht Affairs.
2. Platt JJ (1995) Vocational rehabilitation of drug 
abusers. Psychological Bulletin, 117(3): 416–433.
3. Keane M (2007) Social Reintegration as a 
response to drug use in Ireland. Overview 5. 
Dublin: Health Research Board. 
4. Magura S, Blankertz L, Madison EM, Friedman 
E and Gomez A (2007) An innovative job 
placement model for unemployed methadone 
patients: a randomized clinical trial. Substance 
Use & Misuse, 42(5): 811–828.
Innovative job placement model (continued)
Residential services for alcohol 
and drug users
The National Drugs Strategy (NDS) 2001–2008 
provides the strategic framework for drug services 
in Ireland. The strategy is based on four pillars, 
supply reduction, prevention, treatment and 
research, and is underpinned by 100 actions 
which are the responsibility of various government 
departments and agencies. Through the NDS, 
the Health Service Executive (HSE) (formerly 
the 10 health boards), is mandated to provide a 
range of treatment options, including residential 
components, to drug users experiencing problems.
In 2005, a mid-term review of the NDS 
recommended that rehabilitation be adopted 
as a fi fth pillar of the Strategy. Arising from this 
recommendation, the HSE appointed an expert 
working group in 2006 to describe residential 
treatment services for problem drug and alcohol 
users in Ireland, to calculate their current capacity 
and to estimate future requirements. The report of 
that group has now been published.1
The working group mapped existing inpatient 
detoxifi cation, rehabilitation and aftercare services, 
and reviewed the international literature. The 
literature examined four specifi c areas: models 
of care, the evidence base for opiate and alcohol 
detoxifi cation, methods employed to calculate 
the number of places required for detoxifi cation, 
and the standards for measuring quality of care. 
Available data from existing reporting systems, 
such as the Hospital In-Patient Enquiry scheme, 
Bed type Current provision Total beds required Shortfall
Medical detoxifi cation 
and stabilisation
23 127, of which: 
50% for alcohol (64), and 50% for drugs 
(63)
104
Community-based 
residential detoxifi cation
15 Assessment not completed
Residential rehabilitation 634.5, of which 31% 
are reserved for use by 
people with problem 
alcohol use only
887, of which: between 14 and 37 for a 
specifi c adolescent service; 205 for illicit 
drug users transferring from inpatient 
detoxifi cation services; 382 for problem 
alcohol users transferring from inpatient 
detoxifi cation services; and 300 to 
address the needs of drug or alcohol 
users who have attended outpatient 
detoxifi cation services
252.5
Step-down/halfway 
house
155, of which 76% are 
for use by men only
296 (required by 30% of service users) 141
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and the National Psychiatric In-Patient Reporting 
System, were analysed. A number of submissions 
were made to the group. A population-based 
approach was adopted to estimate the level of 
residential services required. The availability of and 
requirements for residential treatment beds are 
shown in the table below. 
The key recommendations of the working group 
are:
The four-tier model of service delivery, which  ■
offers clients the least intensive intervention 
appropriate to their need, should be adopted 
as the framework for the future delivery of 
alcohol and drug services in Ireland. It was 
acknowledged that the all four tiers need to be 
fully resourced for this model to be effective.
A standardised assessment protocol which  ■
allows for the systematic identifi cation of each 
client’s needs is required.
Inpatient detoxifi cation should, as a rule, be  ■
provided in dedicated units. The transition from 
a detoxifi cation programme to rehabilitation 
should be seamless so as to avoid waiting 
lists, relapse and (in the case of opiates) 
overdose. Detoxifi cation must be followed up 
by rehabilitation and aftercare interventions.
The number of inpatient detoxifi cation and 
residential rehabilitation beds needs to be 
increased (see table above).
Where there is unused capacity at present in  ■
a service or unit because of staffi ng shortages, 
such capacity needs to be brought on stream 
immediately.
In highlighting a defi cit of 356.5 beds  ■
(104 inpatient detoxifi cation and 252.5 
rehabilitation), the working group noted the 
estimated 66 beds in psychiatric units and 
hospitals that are currently used for alcohol 
and drug problems and which will no longer 
be available as a result of the restructuring 
proposed in the report of the expert group on 
mental health policy.2 
Of the estimated 63 beds required for inpatient  ■
detoxifi cation for drug users, one 50-bedded 
unit should be provided between the Dublin 
Mid-Leinster and Dublin North East HSE regions 
where, the data indicate, the majority of opiate 
and benzodiazepine users live. The remaining 
13 beds should be divided between the HSE 
Southern and HSE Western Regions. 
In the case of services focusing primarily on the  ■
treatment of alcohol problems (detoxifi cation 
and residential), the beds need to be evenly 
spread over the four HSE regions (16 per 
region) since the data suggest a more even 
distribution of alcohol-related problems 
throughout the country.
Clients with co-morbidity issues who are in  ■
residential drug and alcohol services should 
be provided with adequate support by the 
mental health services, with clear pathways 
into residential mental health services when 
required. 
There is a need to review community-based or  ■
outpatient detoxifi cation services, including the 
possible role of Level 2 GPs in their provision.
The Prison Service needs to extend its  ■
detoxifi cation and rehabilitation programme 
in Mountjoy Prison, and establish similar 
programmes in all other prisons within the 
State. 
The provision of step-down or halfway-house  ■
accommodation for newly released prisoners 
and homeless people who have been detoxifi ed 
or who have started rehabilitation programmes 
is particularly important.
A unique identifi er and mechanism to track  ■
progression from treatment services to 
rehabilitation is required.
A directory of current residential services needs  ■
to be developed and undated annually.
Families of drug and alcohol users could be  ■
more involved in the overall careplans of 
recovering users. Innovative approaches to care 
for the children of drug users while in treatment 
are required.
The Quality in Alcohol and Drugs Services  ■
(QuADS)3 suite of organisational standards and 
the Drug and Alcohol National Occupational 
Standards (DANOS),4 developed in the UK by 
Alcohol Concern and Drugscope and Skills for 
Health, should be adapted for use by drug and 
alcohol services in Ireland.
There must be quality standards for the  ■
residential facilities themselves, and the HSE 
should discuss with the Health Information 
and Quality Authority (HIQA) the possibility of 
bringing such facilities under the regulation of 
HIQA’s social services inspectorate. This would 
help avoid duplication of effort when quality 
audits are undertaken.
It is particularly important that relevant  ■
stakeholders ensure that all detoxifi cation 
procedures meet the highest standards of 
clinical governance, care and patient safety. 
The level of provision set out in this report  ■
should be reviewed in March 2010.
(Jean Long)
1. O’Gorman A and Corrigan D (2007) Report of 
the HSE working group on residential treatment 
and rehabilitation (substance users). Dublin: HSE.
2. Expert Group on Mental Health Policy (2006) 
A vision for change: report of the expert group on 
mental health policy. Dublin: Stationery Offi ce.
3. Alcohol Concern and DrugScope (1999) 
Quality in Alcohol and Drug Services (QuADS): 
Organisational Standards. London.
4. For more information about DANOS, see the 
Skills for Health website at www.skillsforhealth.
org.uk.
Residential services (continued)
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Regional drugs task force Catchment area
ECRDTF East Coast South Dublin City and County excluding seven LDTF areas, 
East Wicklow
MRDTF Midland  Counties Laois, Longford, Offaly, Westmeath
MWRDTF Mid-Western Counties Clare, Limerick, North Tipperary
NDRDTF North Dublin City and County North Dublin City and County excluding fi ve LDTF areas
NERDTF North East Counties Cavan, Louth, Meath, Monaghan
NWRDTF North West Counties Donegal, Leitrim, Sligo and north-west Cavan
SRDTF Southern Counties Cork, Kerry
SERDTF South East Counties Carlow, Kilkenny, South Tipperary, 
Waterford, Wexford
SWRDTF South West South and West Dublin, West Wicklow and County Kildare 
WRDTF Western Counties Galway, Mayo, Roscommon
RDTF strategies and prevention
In the last issue of Drugnet Ireland the responses of the 
regional drugs task forces (RDTFs) to the Supply Reduction 
pillar of the National Drugs Strategy were considered.1 
In this issue, responses under the Prevention pillar are 
considered. 
The National Drugs Strategy recognises four components 
of Prevention – education, awareness, information, and 
prevention, the last encompassing support for the family, 
and diversionary and structural interventions.2 The strategies 
of the 10 RDTFs3 display a similar range of understandings 
of the concept, but highlight the challenge of choosing 
the right mix of interventions, and providing them at the 
right time in the right places. Different elements of this 
challenge are teased out here. The types of substances being 
used need to be taken into account. For example, in the 
north-west, there is a low level of illegal drug use – mostly 
cannabis and ecstasy – and the principal problems are due 
to polydrug use, under-age drinking and the extent to which 
the drug culture and under-age drinking have become 
intertwined. As a consequence, the RDTF has decided to 
focus on ‘awareness’, with two objectives – to raise the levels 
of awareness of drug misuse and under-age drinking, and to 
research, compile and disseminate relevant and up-to-date 
data regarding drug misuse and under-age drinking in the 
region (NWRDTF: 7).
The age of the target populations and their particular needs 
also have to be taken into account. One RDTF found that 
many education/prevention measures were targeting adults 
(aged over 18), although it was acknowledged that the 
most vulnerable to developing a drug misuse problem are 
primarily those under the age of 16 years. The assumption 
appeared to be that services targeting families and 
concerned others would equip these individuals to have an 
infl uence on their at-risk family members. The RDTF argued: 
‘The capacity of family members to exert their infl uence with 
regard to preventing young people from becoming involved 
in drugs, or in terms of early identifi cation, may need to be 
examined to ensure that resources are being deployed in the 
most effi cient and effective manner’ (SWRDTF: 37–8). 
Another RDTF noted that older age groups had separate and 
distinctive needs: ‘The focus of drug and alcohol campaigns 
is often on young people and their risk-taking behaviours, 
yet it is also important to look at the range of people and 
age groups who may develop problems. While it may 
be true to say that very few older people develop heroin 
problems, they may experience diffi culties with alcohol, 
tranquillisers, sleeping tablets or painkillers. It is important 
to recognise that people may be experiencing dependence 
diffi culties with over-the-counter medications’ (WRDTF: 29). 
Having consulted with education and prevention service 
providers in its region, the SWRDTF reported, ‘There is an 
almost exclusive focus on education as the primary method 
of prevention, which is worrying given the correlation 
between drug misuse and early school-leaving’ (SWRDTF: 
25). Other preventive measures, such as diversion, might be 
more relevant to this population.
The location of services and the channels for the provision 
of prevention services across large regions poses yet another 
set of challenges. The SWRDTF found wide variations in 
the range of education/prevention services provided in 
different settlement areas, with patchy coverage in core 
urban areas, and progressively lower levels of service 
provision in sub-urban commuter towns and in rural areas. 
Conversely, in the ECRDTF it was found that there was an 
over-supply of education/prevention services in comparison 
to treatment, harm reduction and rehabilitation services. It 
was observed that this represented ‘a narrow perspective 
which will need to be widened if the drug problem in the 
area is to be addressed in any comprehensive or coherent 
way’ (ECRDTF: p. 24). Finding that most services operated 
on a basis of open access, the ECRDTF suggested this had 
both advantages and disadvantages: everyone had access 
to a service but those most in need or those whose needs 
could best be met by a particular programme might miss 
out through allocation of places on a fi rst-come – fi rst-served 
basis. It called for more targeted services, run according to 
clear aims and objectives, and evaluated to ensure resources 
are being used effi ciently and effectively (ECRDTF: p. 25).
Co-ordination of services across extensive regions and the 
establishment and maintenance of standards were identifi ed 
as means of coping with the challenges of providing 
appropriate services. Proposed actions included:
drugnet 
IRELAND
11
appoint a prevention co-ordinator to run a  ■
regional education/prevention forum and to 
research, develop and apply a model of best 
practice and early intervention;
set up a regional drugs education forum; ■
establish a unifi ed standard across the voluntary,  ■
community and statutory sectors within drugs 
education/prevention;
increase the level of monitoring and evaluation; ■
provide training of personnel as a way of  ■
enhancing the standard of services;
support existing addiction studies courses;  ■
and fund the development and delivery of a 
locally-based diploma in addiction studies in 
conjunction with local service providers and 
tertiary educational institutions. 
(Brigid Pike)
1. Pike B (2007) RDTF strategies and supply 
reduction. Drugnet Ireland, Issue 23: 4.
2. Department of Tourism, Sport and Recreation 
(2001) Building on experience: national drugs 
strategy 2001–2008. Dublin: Stationery Offi ce. 
Section 6.3.
3. The RDTF strategy and action plan documents 
are held in hard copy in the National 
Documentation Centre, and are available online 
at www.hrb.ie/ndc.
RDTF strategies (continued)
Promoting evidence-based 
practice in drugs task forces
This article reports on the process and outcomes 
of work by the Alcohol and Drugs Research Unit 
(ADRU) of the Health Research Board (HRB) in 
collaboration with the National Drugs Strategy 
Team (NDST) in promoting good practice in 
reducing demand for drugs in local and regional 
drugs task forces. 
This work is in response to the following EU and 
national policy objectives:
EU Drugs Action Plan 2005–2008 calls on  ■
the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) and National 
Focal Points (NFPs)1 to improve coverage and 
dissemination of, and access to, evaluated best 
practice in reducing demand for drugs.
Action 91 of the National Drugs Strategy calls  ■
on the NDST to disseminate models of best 
practice from the work of local and regional 
drugs task forces (LDTFs and RDTFs).
From May to July 2007 ADRU, in collaboration with 
the NDST, ran six workshops with representatives 
from the drugs task forces. The workshops 
introduced participants to: 
Evidence-based practice (EBP) in drug  ■
prevention
EBP in rehabilitation and social reintegration as  ■
core components in an overall drug treatment 
response
the logic-model as a framework for designing  ■
good practice interventions
For the purpose of the workshops, EBP was defi ned 
as practice based on the fi ndings of scientifi c 
research. The examples presented in the workshops 
were drawn from up-to-date systematic reviews on 
‘what works’. This facilitated a discussion on the 
quality and relevance of published research and its 
usefulness to service providers. 
The workshops included a research exercise with 
representatives from the task forces to establish the 
following: 
To what extent is evidence from research  ■
used when strategic and operational plans are 
compiled?
What are the perceptions of and barriers to  ■
using research evidence?
How can the use of research evidence to inform  ■
policy and practice be supported in the future? 
Data were collected through focus groups with 
nine regional drug co-ordinators, 15 development 
workers and a group of 10 people that included 
community liaison workers, project managers, RDTF 
community and voluntary representatives, and an 
RDTF chairperson. 
The main fi ndings from the focus groups were:
Regional and local drugs task forces, for the  ■
most part, have not used research to inform the 
development of their strategic response to drug 
use and associated problems.
The main obstacles to using an evidence- ■
based approach appear to be cultural, with 
communities perceiving research as belonging 
to a different culture, that of the ‘ivory tower’ 
of academia, and having little relevance or 
application to the services being developed in 
communities.
This perceived cultural gap between research  ■
and practice in the communities often results in 
fear among service providers of engaging with 
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research, which is often seen as complex and 
inconclusive
Services are usually planned using what was  ■
reported as ‘a top of the head approach’ – a 
mix of anecdotal evidence and personal 
experience – when deciding the most effective 
way to respond to a particular problem.
However, the focus groups also revealed a 
willingness to engage with and use research 
evidence to inform practice if the appropriate 
supports were in place. It was also felt that task 
force committees and sub-groups could be 
persuaded of the value of engaging with and using 
research evidence if the following measures were 
adopted: 
Take research out of the perceived ‘ivory  ■
tower’ of research institutions and make 
it understandable and relevant to service 
providers. 
Make research evidence available to  ■
communities in an accessible format that does 
not involve having to sift through cumbersome 
research reports.
Present research evidence in a way that allows  ■
service providers to assess the implications for 
their services. 
Support communities with regular training and  ■
education workshops and give service providers 
quality follow-up support.
In early September 2007, the outcomes from the 
workshops were presented to the NDST, with 
recommendations to promote and develop an 
evidence-based culture in the drugs task forces. The 
recommendations were:
Design and run workshops on EBP, targeting  ■
task force committees (and then services).
Explore mechanisms to adopt and implement  ■
EBP with task force committees.
Identify and facilitate the use of evaluation  ■
techniques to assess the effectiveness of an 
evidence-based approach to service delivery. 
Provide technical assistance to task forces  ■
to enable them to design and implement 
small area studies that estimate the extent of 
drug use, and quality assessment criteria for 
interventions.
Liaise with service providers to identity  ■
information needs on ‘what works’ in identifi ed 
areas.
Produce regular and up-to-date bulletins on EBP  ■
in specifi c domains, for example, school based 
prevention, selective prevention, and family 
support 
These recommendations are in line with the main 
outcomes from the focus groups, which identifi ed 
a cultural gap between research and local practice. 
Consequently, there a need to try to bridge this 
gap using a staged approach to supporting local 
communities to shift from a ‘top of the head’ 
approach to the use of research evidence. The 
recommendations are also in line with the four 
main outcomes identifi ed by Proctor2 that must be 
attained if EBPs are to be successfully adopted by 
practitioners:
Motivate and facilitate agency-based 1. 
practitioners to identify and access information 
about available EBPs that have been identifi ed 
by others. 
Identify approaches to bring about acceptance 2. 
of EBPs and facilitate adoption once identifi ed 
and accepted. 
Identify methods that facilitate specifi c 3. 
implementation of EBPs, for example, manuals, 
incentives.
Identify methods to facilitate the evaluation of 4. 
outcomes following implementation to permit 
feedback and revision.
ADRU, in collaboration with the NDST, will continue 
to play a role in disseminating EBP to service 
providers in the regional and local drugs task forces. 
This work will be infl uenced by the ‘translational’ 
model of dissemination as advanced by Lawrence.3 
This model is based on the idea of research being 
translated by ‘knowledge brokers’, making it policy 
and practice relevant. This approach is seen as 
more useful than the traditional linear approach to 
dissemination, which assumes that, when research 
evidence is made available, practitioners have the 
time and interest to read and interpret the results 
and apply them to practice. 
(Martin Keane) 
1. The Alcohol and Drug Research Unit (ADRU) 
is the Irish National Focal Point (NFP) of the 
EMCDDA.
2. Proctor EK (2004) Leverage points for the 
implementation of evidence-based practice. 
Brief Treatment and Crisis Intervention, 4(3): 
227–242.
3. Lawrence R (2006) Research dissemination: 
actively bringing the research and policy worlds 
together. Evidence and Policy, 2(3): 373–384.
Evidence-based practice (continued)
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New law deﬁ nes Minister’s responsibility 
for National Drugs Strategy 
On 9 July 2007 the Community, Rural and Gaeltacht Affairs 
(Miscellaneous Provisions) Bill 2007 was enacted.1 The Act 
provides a coherent statutory mandate for the functions and 
responsibilities of the Minister for Community, Rural and 
Gaeltacht Affairs, including: 
Co-ordinate the implementation of the National Drugs 
Strategy (including matters relating to the allocation of 
services and facilities to counter drug misuse in areas of the 
State where such misuse is signifi cantly higher than in other 
areas of the State). (Section 2 (1) (d))
According to Section 2 (2–4) of the Act, the Minister also 
has the power to develop, implement, maintain, expand or 
terminate any scheme that in her or his opinion supports or 
promotes the functions for which he or she is responsible, 
including the co-ordination of the National Drugs Strategy. 
The precise meanings of ‘National Drugs Strategy’ and 
‘scheme’ are clarifi ed in Section 1 of the Act. ‘National 
Drugs Strategy’ is defi ned as ‘national strategies approved 
from time to time by the Government for the purposes of 
countering drug misuse in the State’. ‘Scheme’ is defi ned as 
‘programmes or measures operated, managed, delivered or 
sponsored, whether in whole or in part, directly or indirectly 
or in conjunction or co-operation with any other person … 
by the Department in relation to the performance of any of 
the functions of the Minister’.
With regard to other ministers and organisations with roles 
and responsibilities for implementing the National Drugs 
Strategy, Minister Éamon Ó Cuív TD stated: ‘It should be 
noted that section 2 [of the Act] does not seek to limit or 
assume in any way the powers, functions and responsibilities 
of other Ministers or State agencies or bodies. Accordingly, 
there is provision in the Bill for appropriate consultation with 
other Ministers.’2 
(Brigid Pike) 
1. Community, Rural and Gaeltacht Affairs (Miscellaneous 
Provisions) Act 2007. Available at www.gov.ie/oireachtas/
frame.htm
2. Ó Cuív É (2007, 3 July) Parliamentary Debates Dáil 
Éireann Offi cial Report: Unrevised. Vol. 637, col. 1246, PDF 
version. Available at www.gov.ie/oireachtas/frame.htm 
The Ballyfermot Hepatitis C 
Campaign is being run to 
raise awareness of hepatitis 
C and of the options for its 
investigation and treatment 
at appropriate services. 
As part of the campaign, 
information booklets were 
published for three different 
audiences – active drug users, 
ex-drug users who injected 
at some time in the past, and 
GPs caring for people with 
hepatitis C. Also part of the 
campaign, the current issue 
of d-Talk is a ‘Hepatitis C 
special’.1
Each booklet covers issues specifi c to the target group, but 
all include information on who is at risk of acquiring hepatitis 
C, facts about the infection, symptoms of acute hepatitis 
C, blood tests and other investigations for diagnosing the 
illness, possibilities for and improvements in treatment, 
side effects of treatment and requirements in order to start 
treatment. The active drug users’ booklet has a section on 
protecting against infection. The ex-drug users’ booklet has 
an expanded section on personal health. The GPs’ booklet 
contains some common beliefs among drug users about 
hepatitis C, and more detailed information on investigation 
and treatment. 
These booklets present accurate factual information and 
are useful not only to the immediate target groups but to 
those living or working with drug users. The booklets can be 
shared with other taskforce 
areas with a high prevalence of drug users. 
(Jean Long) 
1. The longer we ignore hepatitis C the bigger the problem 
will get. d-Talk, Autumn 2007, Issue 6. (Produced by 
Ballyfermot Advance, with support from the Ballyfermot 
LDTF.)
For further information and copies of the booklets, please 
contact: 
Ballyfermot Advance Project 
Le Fanu House, 
3b Le Fanu Road 
Ballyfermot 
Dublin 10
tel: 01 6238001 
email: info@ballyfermotadvance.ie
Ballyfermot Drugs Task Force hepatitis 
C campaign
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The third Irish HBSC (Health Behaviour in School-aged 
Children) study,1 conducted in 2006 by the Health 
Promotion Research Centre in the National University of 
Ireland, Galway, was published in August 2007. HBSC is a 
cross-national research study conducted every four years in 
collaboration with the World Health Organization, and in 
2006 there were 41 participating countries and regions. The 
overall aims of the HBSC are to gain insight into and increase 
understanding of young people’s health and well-being, 
health behaviours and their social context. 
HBSC is a school-based survey with data collected through 
self-completed questionnaires administered by teachers in 
the classroom. The sampling frame consisted of primary and 
post-primary schools. A two-stage process identifi ed study 
participants: individual schools within regions were fi rst 
randomly selected, and class groups were then randomly 
selected for participation. Sixty-three per cent of invited 
schools and 83% of students sampled participated in 
the 2006 HBSC survey. Data were collected from 10,334 
children aged 10–18 years on topics including general 
health, smoking, use of alcohol and other substances, food 
and dietary behaviour, exercise and physical activity, self-
care, injuries and bullying. This article describes the results 
pertaining to the use of alcohol and other substances, and 
makes comparisons with the previous HBSC surveys. 
Overall, 47% of children reported that they had never had 
an alcoholic drink, up from 40% in 2002 and 31% in 1998. 
The percentage of girls (52%) reporting that they had 
never had an alcoholic drink was higher than that for boys 
(43%), and there was little evidence of a social class effect. 
This is the only variable that showed a marked change from 
previous HBSC studies. The proportion of children reporting 
having had an alcoholic drink in the past month (defi ned 
as current drinkers) was 26%. This has remained stable 
between 2002 and 2006, except in the case of 15–17-year-
old boys, where a small decrease is evident. 
Children were asked if they had ever been ‘really drunk’. In 
total, 32% of children reported having been drunk, with 
large age differences but little variation by gender or social 
class; 5–7% of 10–11-year-olds and 53–58% of 15–17-year-
olds reported ever being drunk, with little change since 
2002. One in fi ve children reported being drunk in the 
previous 30 days, with large differences between age 
groups. Over a third of boys and girls aged 15–17 reported 
being drunk in the previous 30 days. 
This report also studied cannabis use among children. 
Overall, 16% of children reported using cannabis during 
their lifetime, compared with 12% in 2002; 12% reported 
using cannabis in the past 12 months, compared with 11% 
in 2002. Cannabis use was highest for those aged 15–17, 
Third HBSC study reports ﬁ ndings
Substance misuse in the HSE South 
Eastern Area 
The Health Service Executive (HSE) South Eastern Area 
published its annual report, Data co-ordination overview of 
drug misuse 2006, in September 2007.1 The report comprises 
four sections: recent developments, treatment services, 
education and prevention, and supply and control. 
The section on treatment services analyses data collected 
from statutory and voluntary drug and alcohol treatment 
agencies, acute general hospitals and psychiatric hospitals 
in the HSE South Eastern Area. The data from the drug and 
alcohol treatment services are returned to the National Drug 
Treatment Reporting System in the Health Research Board. 
The total number of contacts with treatment services in 
2006 was 2,641, a decrease of 145 cases on the 2005 
fi gure. The report notes that the decrease was due to a staff 
vacancy in Carlow, and staff absences on maternity and sick 
leave in services in other areas. Contacts with treatment 
services include those by clients continuing in treatment 
from the previous year, clients who were assessed but not 
treated, clients who were treated, and concerned persons. 
Some 115 concerned persons, family members or close 
friends of substance users, contacted treatment services in 
the south-east in 2006. 
The combined total of new referrals who were treated and 
clients who returned to treatment after an absence was 
1,880. Of these: 
71% were male and 29% female. ■
8% were under the age of 18, and 44% were aged  ■
between 20 and 34.
Alcohol (67%) was the most common main problem  ■
substance for which treatment was sought, followed by 
cannabis (14%) and heroin (9%). 
The number of clients whose main problem substance  ■
was cocaine remained stable at 86.
Of the 1,022 clients who had used a drug, 80% reported  ■
that cannabis was the fi rst drug they had ever used.
776 (41%) clients reported using a secondary substance,  ■
the main ones being cannabis (347), alcohol (121) and 
ecstasy (97). 
60% of clients treated for alcohol and 61% treated for a  ■
drug as their main problem substance were treated for 
the fi rst time. 
Of 2,506 clients treated in the south-east in 2006 (including 
clients continuing in treatment from the previous year), 58 
(2%) had injected a substance. 
The data presented in this report are useful for planning 
future services. 
(Jean Long) 
1. Kidd M (2005) Data co-ordination overview of drug misuse 
2006. Waterford: HSE South Eastern Area. 
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Coolmine Therapeutic Community 
annual report 2006 
Coolmine Therapeutic Community was established in 
1973. Its mission is to ‘provide the best quality residential 
and community services possible, in order to empower 
people to end their dependence on drugs and alcohol and 
to help them realise their right and potential to become 
participating and valued members of society.’1 Coolmine’s 
facilities are located in the Dublin area, but they offer a 
service country-wide. A year of change: annual report 2006 
was published in October 2007.2
According to the report, Coolmine has incorporated the 
Homeless Agency’s holistic needs assessment in their case-
management system to ensure that all of their clients’ needs 
are taken into consideration. The organisation is committed 
to providing a ‘continuum of care’, and in 2006 they 
launched two new initiatives: the Welcome Programme and 
the Integration and Aftercare Service.
The Welcome Programme, based at 112 Cork Street,  ■
Dublin 8, provides a tailor-made programme of care for 
clients who are struggling to become and/or remain 
drug free. The programme includes counselling, group 
work, support in accessing accommodation, guidance 
on detoxifi cation options and introduction to the 
most appropriate service providers. It can cater for a 
maximum of 12 clients at any one time. This programme 
was accessed by 65 clients in 2006, of whom 18 had 
achieved their planned goals by the end of the year. 
The Integration and Aftercare Service provides support  ■
to clients as they negotiate the transition from treatment 
back into the community, and provides step-down, 
community-based housing for a minimum of six months. 
In 2006, the programme provided services to 36 clients. 
Coolmine also provides the following services: 
Outreach Services, based at 19 Lord Edward Street,  ■
provide a 9am–5pm drop-in facility, along with an 
outreach service to a number of prisons and homeless 
services in Dublin city and the midlands. In 2006, the 
outreach workers assessed 393 people in the community, 
of whom 140 entered one of the Coolmine services; 
they also assessed 129 people in prison, of whom 33 
entered a community-based service. Coolmine staff 
also provided 51 group counselling sessions in 2006 for 
clients who completed the detoxifi cation programme at 
the Mountjoy Prison Medical Unit.
The Drug Free Day Programme, also based at Lord  ■
Edward Street, provides a six-month, abstinence-based, 
rehabilitative programme for 12 clients at any one time. 
In 2006, 27 clients participated in the programme, 
nine of whom progressed to aftercare and integration 
services. The programme provides a safe environment 
where clients can develop skills for a drug-free and 
independent way of life. 
The Women’s Residential Service at Ashleigh House,  ■
Clonee, Co Meath, offers women a safe environment in 
which to address substance use issues and associated 
behaviours. This six-month programme accommodates 
a maximum of eight women at any one time, with plans 
to increase this number to 12 in 2007. There were 17 
admissions during 2006.
The Men’s Residential Service at Coolmine Lodge, Grove  ■
Road, Clonsilla, gives clients the support and opportunity 
to tackle and overcome drug dependency and its 
associated behaviours. The nine-month programme can 
cater for up to 30 men at any one time. There were 74 
admissions during 2006.
Family Support Services engaged a dedicated staff  ■
member in 2006 to work with families and signifi cant 
others in crisis and to facilitate weekly support groups. 
The priorities for Coolmine in 2007 are to increase staffi ng 
levels and staff–client ratios in all services, provide crèche 
and child-care facilities in the women’s service, and provide a 
step-down and aftercare facility for those attending services 
in Cork city and county. 
(Anne Marie Carew)
1. See the Coolmine Therapeutic Community website at 
www.coolminetc.ie.
2. Coolmine Therapeutic Community (2007) A year 
of change: annual report 2006. Dublin: Coolmine 
Therapeutic Community.
with about one in fi ve in this age group using cannabis in 
the previous 12 months. There was little evidence of a social 
class effect. The rates of reported cannabis use are similar to 
those in the 2002 HBSC study, except among 15–17-year-
old boys, where a decrease is evident. 
Seven per cent of children reported using cannabis in the 
previous 30 days. This was slightly higher for boys (8%) 
than for girls (5%). Those aged 15–17 were more likely to 
report recent cannabis use than younger children. A clear 
social class effect was evident among 15–17-year-old boys 
regarding recent cannabis use; 10% of boys in the highest 
social class grouping reported recent cannabis use compared 
to 15% in the lowest social class grouping.
In conclusion, there was little marked change between 2002 
and 2006 in reported alcohol and cannabis use, except in 
the percentage that had never had an alcoholic drink, which 
increased over the period. In general, there appeared to be 
little evidence of a social class effect, except in the case of 
cannabis use in boys aged 15–17 years. Similarly, there were 
few gender differences, except in the case of children who 
had never had an alcoholic drink. 
(Deirdre Mongan)
1. Nic Gabhainn S, Kelly C and Molcho M (2007) The Irish 
Health Behaviour in School-aged Children (HBSC) study 
2006. Dublin: Department of Health and Children.
HBSC study (continued)
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Help and advice on coping with the 
death of someone close
In its vision statement and guiding principles, the 
National Strategy on Suicide Prevention 2005–2014 
proposed that ‘those affected by a suicide death 
or deliberate self-harm receive the most caring 
and helpful response possible’.1 To assist this 
process, the strategy proposed a review of the 
existing information and resources available to 
the bereaved. In response, the National Offi ce for 
Suicide Prevention has published the two booklets 
outlined below.
You are not alone: 
help and advice 
on coping with the 
death of someone 
close provides 
practical advice and 
support to those 
who have been 
affected by suicide 
or an unexpected 
death.2 The booklet 
is divided into fi ve 
sections: immediate 
reactions; natural 
responses; events 
that occur following 
a death; sorting out your affairs; and getting help 
for you and your family. Each section deals with the 
different stages of the bereavement process.
Immediate reactions and natural responses 
recognise that the circumstances surrounding 
suicide can be overwhelming and diffi cult to 
understand. The aim of these sections is to guide 
the bereaved through their feelings of anger, guilt 
and depression both in the initial stages and in the 
months following the death. The second of the 
sections addresses the behaviour and emotions that 
can be expected from a child who has lost a parent, 
sibling or loved one. It provides ways of breaking 
the news to a child and methods to keep channels 
of communication open.
When a death occurs by suicide or is unexpected, 
certain legal procedures must be followed. Events 
that occur following the death introduces 
and describes the role of all the parties involved 
following the death, including that of the gardai 
and the coroner. The term and process of a post-
mortem and its effect on funeral arrangements are 
explained. Due to the nature of a suicide death, 
an inquest will be held and a brief description of 
the inquest proceedings is given. This can delay 
the issuing of a death certifi cate, but again an 
explanation is given on how to obtain an interim 
certifi cate from the coroner.
Sorting out your affairs addresses money matters, 
such as how to access social welfare entitlements 
and funds lodged in banks, post offi ces, or 
insurance policies. Advice is provided on registering 
a death, who deals with a will or what do in the 
absence of a will. The terms ‘intestacy’, ’probate’, 
‘executors’ and ‘administrators’ are explained.
The fi nal section, getting help for you and your 
family, lists the types of support that are available 
and mentions how people are referred to the 
mental health services in Ireland. 
You are not 
alone: directory 
of bereavement 
support services 
2007 is a guide to 
bereavement support 
services available 
throughout Ireland.3 
Specifi c support 
services for those 
who are bereaved 
due to suicide are 
highlighted. The 
booklet provides 
contact details 
for multi-branch 
organisations, including Barnardos Bereavement 
Counselling for Children, Samaritans and Console. 
The directory includes voluntary, community-based 
and self-help groups, and private counsellors.
The role of the HSE Resource Offi cer for Suicide 
Prevention is to guide bereaved people to the 
most appropriate support service available, and 
to support the service providers. Contact details 
for the resource offi cers throughout Ireland are 
listed, as are key contacts such as ISPCC, GROW 
and Aware. Irish and international websites are also 
listed, along with suggested reading. 
These booklets will be useful to those who are 
bereaved, particularly by suicide or sudden 
death. They have been distributed to GPs, funeral 
directors, gardaí, resource offi cers and registered 
counsellors, and can be downloaded from www.
nosp.ie. Further information is available from the 
National Offi ce for Suicide Prevention, Dr Steevens’ 
Hospital, Kilmainham, Dublin 8. Tel: 635 2179; 
Email: info@nosp.ie. 
(Simone Walsh) 
1. Health Service Executive, National Suicide 
Review Group and Department of Health and 
Children (2005) Reach out: national strategy for 
action on suicide prevention 2005–2014. Dublin: 
Health Service Executive.
2. Health Service Executive (2007) You are not 
alone: help and advice on coping with the death 
of someone close. Dublin: National Offi ce for 
Suicide Prevention.
3. Health Service Executive (2007) You are not 
alone: directory of bereavement support services 
2007. Dublin: National Offi ce for Suicide 
Prevention.
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Crosscare Teen Counselling 
annual report 2006
The 2006 annual report from the Crosscare Teen 
Counselling service was published recently.1 The 
report brings together information from the fi ve 
teen counselling centres operated by Crosscare in 
Dublin. The overall aim of the counselling service is 
to enable young people and their parents or carers 
deal with family confl ict, mental health, substance use 
and behavioural issues among teenagers within the 
context of the family. The service saw 400 families in 
2006, which included 248 new cases and 152 cases 
carried forward from 2005. Of the new cases, 44% of 
teenagers were living with both biological parents and 
85% were in secondary school. Sixty-seven per cent of 
new teenage clients were aged under 16 and 55% of 
these were female. Fifty per cent of new teenage clients 
reported drinking alcohol and 23% reported using a 
drug other than alcohol, with cannabis (17%) the most 
popular. 
The report includes results from an internal evaluation of 
the service in 2006 based on four strands:
Parents were asked to assess the severity of 1. 
problems they were experiencing and their ability 
to deal with them at baseline and again when 
therapy was completed. Sixty-fi ve per cent of 
parents who completed this process reported a 
great reduction in the severity of problems and 
34% reported some reduction. Fifty-four per cent 
said their ability to cope had greatly improved and 
45% said there was some improvement. 
Teenagers were asked to assess the severity of their 2. 
diffi culties at baseline and again when therapy 
was completed across four domains: at home, 
in school, among friends and self. Improvement 
was reported in all domains, with 96% reporting 
improvement in relation to problems they 
attributed to self. (Table 1). 
Counsellors evaluated all cases that had completed 3. 
therapy in 2006 (n=256) on the severity of 
problems that they presented with and their 
underlying problems. Thirty-nine per cent 
reported improvement in the problems families 
presented with and 44% reported improvement in 
the underlying problems. 
Counsellors used the Global Assessment of 4. 
Relationships Functioning DSM-IV to measure 
family functioning at baseline and again at therapy 
completion. When therapy had completed the 
average for family functioning was scored at 87, 
an increase from 56 at baseline. Higher scores 
are indicators of improved functioning among 
families. 
Counsellors used the Global Assessment of 
Functioning DSM-IV to assess how well teenagers 
were functioning at baseline and again when therapy 
was completed. On completion, the average score 
was 69, an increase from 58 at baseline, indicating 
that some improvement had occurred. 
However, the results of this evaluation must be treated 
with a degree of caution as it cannot be defi nitively 
shown that the improvements reported by participants 
and staff were due to the intervention because the 
evaluation did not control for competing explanations. 
For example, the severity of problems could have 
reduced with the passage of time and the capacity of 
parents/teenagers to cope with problems could have 
improved with time, without either being affected 
by the intervention. Given that families received 
counselling for an average of nine months, the issue 
of time is important. One way that the evaluation 
could have controlled for this competing explanation 
would have been to compare parents and teenagers 
receiving the intervention (experimentals) with a group 
of similar parents/teenagers on the waiting list for the 
intervention (controls). The report notes that 41% of 
referrals to the programme in 2006 were placed on a 
waiting list.
Despite the limitations of the evaluation design, 
it would appear that the Teen Counselling service 
provides a much-needed response to families in 
distress and is well regarded by professionals. The 
majority of referrals to the service were by schools, 
family doctors, psychologists, counsellors, social 
workers and health professionals. Engaging and 
maintaining participants in counselling presents 
challenges to service providers targeting ‘at risk’ 
families. The report notes that including parents in 
the work and providing a locally based service that is 
not stigmatised are key elements in the success of the 
service. 
(Martin Keane) 
1 Teen Counselling (2007) Teen Counselling annual 
report 2006. Dublin: Crosscare.
Table 1  Percentage of teenagers reporting improvement following therapeutic intervention
Greatly improved (%) Improved (%) No change (%)
Home 22 50 28
School 13 60 23
Friends 30 30 40
Self 38 58 4
Source: Teen Counselling (2007)
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Heroin use and drug injecting have 
become ‘generally less common’, 
and cannabis use may be stabilising, 
according to the Annual Report 2007: 
the state of the drugs problem in Europe, 
published by the European Monitoring 
Centre for Drugs and Drug Addiction 
(EMCDDA) in November.1 However, 
the level of drug-related deaths 
remains high and the use of cocaine 
is increasing. Irish data for the report are provided by the 
Alcohol and Drugs Research Unit of the HRB.
Cocaine
Cocaine remains Europe’s second most commonly used 
illicit drug, after cannabis. The EMCDDA estimates that 12 
million European adults (aged 15–64) have tried cocaine, 
and 4.5 million have used it in the last year. Most countries 
reported increases in last-year usage among young adults 
(aged 15–34). However, slight increases in countries with 
the highest prevalence — Spain and the UK — suggest that 
prevalence may be levelling off. Cocaine accounts for 13% 
of cases entering treatment across the EU and is the most 
common reason for entering treatment, after opiates (mainly 
heroin), and cannabis. A total of 22% of new cases entering 
treatment in 2005 were cocaine related. The number of 
new clients rose from 12,633 in 1999 to 33,027 in 2005, 
an indication of the impact on public health. In 2005 a 
record 107 tonnes of cocaine were seized, up over 45% on 
quantities seized in 2004.
In Ireland cocaine is the third most commonly used illicit 
drug, after cannabis and ecstasy and was the third most 
common reason for entering treatment, after opiates and 
cannabis. According to the most recent general population 
survey, 3% of Irish adults (aged 15–64) had used cocaine 
at some point in their lives; just over 1% had used it in the 
year before the survey. Just under 3% of young adults (aged 
15–34) had used cocaine in the last year, while the European 
average was almost 2.5%.
Cannabis
Cannabis remains the most commonly consumed illicit drug 
in Europe. Nearly a quarter of all Europeans have used it at 
some point in their lives and 7% have used it in the past 
year. Almost a quarter of young adults had used cannabis 
in their lifetime, and 9% had used it in the past year. Latest 
data suggest that cannabis use is now stabilising or falling, 
particularly in high-prevalence countries. An estimated 1% of 
European adults — around 3 million people — may be using 
the drug on a daily, or almost daily, basis and the EMCDDA 
intends to focus on improving monitoring of this pattern of 
intensive consumption.
2007 report on the drugs problem in 
Europe
Focus on methamphetamine
The Garda National Drugs Unit recently undertook a project 
in partnership with the UK and Sweden, and funded by 
the AGIS programme, which examined the potential threat 
posed by the increased incidence of methamphetamine 
use throughout the EU, and remedies undertaken to date 
by respective agencies, including law enforcement, forensic 
science and customs services. As part of the project, study 
visits to centres of expertise in partner and participating 
countries took place between March and October 2007, and 
a uniform questionnaire was completed in 10 countries to 
elicit relevant information. 
The project culminated in an international conference 
in the Nuremore Hotel, Co Monaghan, from 26 to 28 
November 2007. The aim of the conference was ‘to 
establish a threat assessment for the increase in availability 
of methamphetamine within the European Union’. The 
seminar was launched by Assistant Garda Commissioner 
Martin Donnellan. Throughout the three-day conference, 
presentations were given on:
the role of Eurojust in the fi ght against serious cross- ■
border and organised crime
UK and US perspectives on methamphetamine ■
a Swedish perspective on methamphetamine in the  ■
Nordic region
A series of workshops discussed the following topics:
Observations on methamphetamine abuse and the  ■
threat which it poses within the EU
Legal frameworks on the control of illegal drugs and the  ■
need to have suffi cient, modern legislation concentrated 
on illegal drug controls
International and interagency co-operation and the need  ■
for law enforcement agencies to have a professional and 
organised approach to co-operation between agencies
The role of forensic science laboratories in helping  ■
law enforcement personnel to combat the threat of 
methamphetamine
Synthetic drug laboratories, and the amount of expertise,  ■
knowledge and equipment required by law enforcement 
personnel to safely identify, investigate and dismantle 
them
Drug treatment policies and the range of health and  ■
socio-economic harms that synthetic drug abuse poses 
to users and society.
Recommendations emerging from the workshops called for 
the regulation of precursor chemicals used in the production 
of synthetic drugs; protocols to deal with laboratories, 
including health and safety and enforcement issues; EU-
shared profi ling of precursor chemicals involved in synthetic 
drug synthesis; a standardised approach to the forensic 
analysis of precursor chemicals; and a co-ordinated EU 
framework to tackle the needs of law enforcement agencies 
in the fi ght against methamphetamine. A full report on the 
conference is due in early 2008. 
(Lorraine Coleman and Johnny Connolly)
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There is no available evidence to determine trends in 
cannabis use among the general population in Ireland. 
The 2003 survey reported that one in fi ve adults had used 
cannabis at some point in their lives and one in twenty had 
used it in the year before the survey. A quarter of young 
adults had used cannabis in their lifetime, and 9% had used 
it in the past year. One in fi ve cases entering treatment in 
2006 reported cannabis as their main problem drug.
Injecting drug use and blood-borne infections
Although injecting drug use has become less important 
as a route of HIV infection, the EMCDDA estimates that 
it accounted for 3,500 new cases of HIV in the EU during 
2005. Hepatitis C Virus (HCV) is more prevalent than HIV 
among injecting drug users and it is more evenly distributed. 
In contrast to their success in preventing HIV infection, 
prevention and harm reduction services seem to be having 
a weaker impact on preventing HCV. Seven in every ten 
injecting drug users in Ireland test positive for the hepatitis 
C virus. Ireland is currently defi ned as a high-prevalence 
country for this disease. One in ten injecting drug users in 
treatment is HIV positive. 
Drug-related deaths
The EMMCDA reports historically high levels of drug-related 
deaths. Between 7,000 and 8,000 people died as a result 
of drug use in 2005. The downward trend in drug-related 
deaths between 1999 and 2002 began to reverse in 2003 
and has accelerated since then. ‘There is an urgent need 
to research why drug-related deaths remain so high’, said 
EMCDDA Director Wolfgang Götz.
Drug use and related problems among very young people
Illicit drug use among under-15s is rare in Europe, and 
children account for less than 1% of all treatment clients. 
Regular drug use among this group is extremely rare and 
is associated with specifi c groups in the population where 
there is a combination of psychological and social problems. 
Cannabis is the most common illicit substance used among 
this age group, followed by inhalants (glue and aerosols). 
Between 5% and 36% of school students have been drunk 
at least once by the age of 13, and between 7% and 18% 
have smoked tobacco. 
The situation in Ireland closely refl ects fi ndings reported 
across Europe, in prevalence, treatment fi gures and the 
most common drugs used. The National Health Behaviour 
in School-aged Children survey indicates that the proportion 
of boys aged 12–14 who reported using cannabis in the 12 
months prior to the survey decreased from 11% in 1998 
to 7% in 2006. Almost one-quarter (24%) of Irish children 
reporting having been drunk by the age of 13.
Drugs and driving
After alcohol, cannabis and benzodiazepines are the 
psychoactive substances most prevalent among the 
European driving population. Many countries have 
responded by tightening laws, increasing penalties or 
altering national strategies to address drugs and driving 
problems. Responses vary greatly, from zero tolerance 
(sanctioning detection of the substance per se) to 
impairment laws (sanctioning if a person is deemed fi t 
to drive). 
The main evidence in relation to drugs and driving in Ireland 
comes from a nationwide survey conducted by the Medical 
Bureau of Road Safety in 2000–2001. The survey found 
that 68% of drivers tested who had zero levels of alcohol 
were positive for more than one drug. Legislation allowing 
random breath testing for alcohol was introduced in Ireland 
in July 2006. Since then there has been a decrease of 19% in 
road accidents and a total of 17,788 drink-driving arrests. 
(Brian Galvin)
1. EMCDDA (2007) Annual Report 2007: the state of 
the drugs problem in Europe. Luxembourg: Offi ce for 
Offi cial Publications of the European Communities. 
www.emcdda.europa.eu/
Drugs in Europe (continued)
EU to fund drug prevention and 
information initiatives
In September 2007 the European Union established a Drug 
Prevention and Information programme for the period 
2007-2013, with a budget of €21.35 million spread over 
seven years.1 The European Commission plans to issue 
the fi rst call for proposals for action grants in December 
2007, and the work programme for 2008, with a budget 
of €3 million, will be announced in January. Further details, 
including eligibility criteria, can be found in the OJEU.2 
The Drug Prevention and Information programme builds on 
the EU Drugs Strategy and Action Plan, the ultimate aim of 
which is to signifi cantly reduce the social harm and health 
damage caused by the use of, and trade in, illicit drugs. The 
general objectives of the programme are:
to prevent and reduce drug use, dependence and drug- ■
related harms; 
to contribute to the improvement of information on the  ■
effects of drug use; 
to support the implementation of the EU Drugs Strategy.  ■
The Programme supports projects and activities associated 
with three specifi c objectives:
to promote transnational actions to: 1. 
set up multidisciplinary networks that can make • 
a clear and specifi c contribution to achieving the 
objectives of this programme; 
ensure the expansion of the knowledge base, the • 
exchange of information and the identifi cation 
and dissemination of good practice, e.g. through 
training, study visits and staff exchanges; 
raise awareness of the social and health problems • 
caused by drug use and to encourage an open 
dialogue with a view to promoting a better 
understanding of the drug phenomenon; and 
support measures aimed at preventing drug use, • 
reducing drug-related harm, and treatment, taking 
into account the latest state of scientifi c knowledge; 
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to involve civil society in the implementation and 2. 
development of the EU Drugs Strategy and Action Plans; 
and 
to monitor, implement and evaluate the implementation 3. 
of specifi c actions under the Action Plans 2005–2008 and 
2009–2012. 
The target groups of the programme’s activities are all 
those who may be affected by the consequences of drug 
use, including young people, pregnant women, vulnerable 
groups and problematic neighbourhoods. Other target 
groups are: teachers and educational staff, parents, 
social workers, local and national authorities, medical 
and paramedical staff, judicial staff, law enforcement and 
penitentiary authorities, NGOs, trade unions and religious 
communities. These groups are also potential benefi ciaries of 
the programme. 
The Drug Prevention and Information programme is just one 
of fi ve instruments contained in the framework programme 
‘Fundamental Rights and Justice’, which aims to promote the 
development of a European society based on EU citizenship 
and which is respectful of fundamental rights. In turn, this 
framework programme, together with the EU Drugs Strategy 
and Action Plan, forms part of the Hague Programme, which 
sets out the EU’s overall objectives in the area of freedom, 
security and justice in the period 2005–2010. 
(Brigid Pike) 
1. Decision No 1150/2007/EC of the European Parliament 
and the Council, 25 September 2007. 
2. Offi cial Journal of the European Union, 3 October 2007, 
L 257/23–29. 
Civil Society Forum on Drugs in the EU 
due to meet 
The fi rst meeting of the Civil Society (CS) Forum on Drugs 
in the EU will take place in Brussels on 13 and 14 December 
2007. Two Irish-based civil society organisations, and 
one Irish-based Europe-wide network, are among the 26 
networks and organisations invited to participate:
CityWide Drugs Crisis Campaign • www.citywide.ie
Drug Policy Action Group • www.drugpolicy.ie 
Eurad • www.eurad.net 
It is expected that at this preliminary meeting rules and 
procedures for the operation of the Forum will be discussed 
and agreed between the European Commission and CS 
representatives.
A report published earlier this year by the Commission1 
outlined the direction and shape that the Commission 
envisages for this Forum. In the report the Commission 
proposed the following mission statement: 
The Civil Society Forum on Drugs will serve as a platform 
for informal exchanges of views and information 
between the Commission and civil society organisations 
in the EU, candidate countries and, as appropriate, 
European Neighbourhood Policy countries. The aim is 
to increase informal consultation and the input of civil 
society on drug-related activities, policy proposals, policy 
implementation and priorities of the EU Drugs Strategy 
and the EU Action Plan on Drugs.
The Commission proposed that the Forum should take 
full account of the six main conclusions from the open 
consultation on the Green Paper on the role of civil society in 
drugs policy in the EU:
The Forum should represent a wide spectrum of views in 1. 
a balanced way.
The Forum should be inclusive rather than exclusive, 2. 
with transparent selection criteria.
The Forum should have a clear mandate, well defi ned 3. 
agendas, transparent procedures and achievable work 
plans with real input into the policymaking process.
The Forum should be able to ensure continuity of the 4. 
work and at the same time be fl exible enough to adapt 
to changing CS and policy challenges. 
The Forum should have adequate fi nancial and human 5. 
resources.
Thematic networks could be organised as subgroups of 6. 
the Forum or separately.
Membership criteria for the Forum were proposed as follows:
The organisation has to correspond to the concept of 1. 
civil society as set out in the Green Paper.
The organisation has to have its main base of operation 2. 
in an EU member state or a candidate country. 
Organisations from European Neighbourhood Policy 
countries may also participate, when appropriate.
Priority will be given to those organisations that are 3. 
established in the form of transnational networks 
covering a number of member states and/or candidate 
countries.The organisation has to have drug-related 
activities as the core focus of it activities.
Credibility: The organisation should have a clear track 4. 
record of its activity.
Representativeness: The organisation should be 5. 
recognised as being able to speak on behalf of those it 
claims to represent.
The organisation must be legal and registered in a 6. 
member state or candidate country.
Membership of the organisation must be open to those 7. 
that meet transparent criteria and the organisation must 
be fi nancially accountable.
Finally, the Commission recommended that membership 
should be for a period of two years, and renewable, to 
ensure both fl exibility and continuity. The maximum size of 
the Forum should be 30 members. 
(Brigid Pike) 
1. Report on the results of the open consultation: Green 
Paper on the role of civil society in drugs policy in the 
European Union. (COM (2006) 316 fi nal). European 
Commission, Brussels, 18 April 2007. For more 
information on the Green Paper, see Pike B (2006) Civil 
society to have role in EU drugs policy. Drugnet Ireland, 
Issue 19: 19–20. 
EU to fund initiatives (continued)
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Minister’s contribution to Trinity 
cannabis debate 
In its opening debate of the current academic 
year, the Trinity College Historical Society debated 
the motion ‘That the sale of cannabis should be 
legalised’. Speaking in favour of the motion were 
Senator Ivana Bacik, Reid Professor of Criminal Law 
at TCD, and Dr Paul Quigley of the Drug Policy 
Action Group. Opposing the motion were Pat 
Carey TD, Minister of State for the national drugs 
strategy, and Johnny Connolly, research offi cer with 
the Health Research Board. 
Minister Carey set out in some detail the 
government’s position on this controversial issue. 
With regard to the health effects of cannabis 
use, the Minister argued that cannabis cigarettes 
produced ‘three times more carcinogenic “tars” 
than tobacco and fi ve times more poisonous 
carbon monoxide’ and that this put users at risk 
‘of bronchitis and double(d) the risk of certain 
types of cancer, including lung and throat cancer’. 
Referring to the association between cannabis use 
and mental illness, the Minister stated that long-
term cannabis use could, in some cases, ‘trigger 
mental illness such as schizophrenia and depression 
– two sicknesses that cannot afford to be promoted 
considering this country’s intolerable suicide rates’.
It is often argued that cannabis operates as a so-
called ‘gateway’ to other illicit drugs. The Minister 
stated that the ‘vast majority’ of young people 
who have used a variety of illegal substances 
initiated their illicit drug consumption with 
cannabis. Consequently, ‘they become involved 
and immersed in the drug culture’, come to know 
drug dealers and ‘more often then not’ come 
into contact with users of drugs of a more serious 
nature.
With regard to the potency of cannabis, the 
Minister suggested that, while previously most 
cannabis contained approximately 2% of the 
active substance THC, newer ‘specially cultivated 
strains of cannabis can be up to 16% THC’. 
He acknowledged, however, that these ‘newer 
strains’ are not the most commonly used types of 
cannabis in Ireland. The Minister, who is a former 
schoolteacher, highlighted research which, he 
said, pointed to a connection between cannabis 
use and early school leaving. While cannabis use 
is, Minister Carey stated, ‘far from the only factor 
stopping teenagers and young adults reaching their 
educational potential, it seems somewhat ridiculous 
to me that we would risk further exacerbating the 
already existing diffi culties by legalising cannabis.’
With regard to the reclassifi cation of cannabis to a 
Class C drug in the UK, the Minister stated that:
equivalent penalties continue to be much 
higher than those currently in force in this 
country. The changes in the UK appear to 
allow greater discretion in dealing with people 
found to be in possession of cannabis. Under 
Irish law, the Gardaí and the Courts already 
have a very high degree of discretion in 
dealing with these cases. Furthermore, Jack 
Straw, UK Secretary of State, indicated recently 
that he personally was in favour of reclassifying 
cannabis to a Class B drug.
Referring to developments in the Netherlands, 
the Minister said:
The Mayor of Rotterdam recently announced 
that 27 of its 62 coffee shops must close as 
of January 1, 2009, because these shops are 
located too close to secondary and vocational 
schools. This is part of a rowing back to a 
degree by Holland at both national and at 
local level of its existing perceived ‘liberal’ 
policy. The relative toleration of cannabis use 
there is down to a wholly pragmatic view 
based on their so-called ‘gedogen’ principle. 
This principle refl ects an ambivalence with 
respect to whether the drug should be legal 
or illegal. It is used in relation to a situation or 
activity that technically is illegal, but which is 
actively tolerated as a matter of government 
policy – since everyone knows the issue (say 
prostitution or the use of soft drugs) can 
not be legislated out of existence. However, 
along with this tolerance, there is a relatively 
hard line taken, with licences for new coffee 
shops being rarely given and many municipal 
governments following a so-called extinction 
policy. The number of ’coffee shops‘ in 
Holland has reduced from 1,500 in 1995 to 
approximately 700 now.
The Minister argued that, although the level 
of acceptance of cannabis use is growing, ‘the 
majority of people in Ireland… are against the 
legalisation of cannabis. This is a fundamental 
reason in a democracy as to why you wouldn’t 
legalise a drug.’ Finally, the Minister questioned 
the assertion that legalisation would result in 
the elimination of criminal activity surrounding 
cannabis. ‘It may’, he argued ‘only result in a 
transfer from drug related criminal activity to other 
forms of criminal activity.’ Even if cannabis were 
legalised, he suggested, ‘it is diffi cult to envisage 
that its provision would be anything other than 
heavily regulated. This would provide continued 
opportunities for criminals to continue their 
involvement in the illegal supply of cannabis.’ 
The motion was defeated by a narrow majority. 
(Johnny Connolly)
Recordings of all the speakers’ contributions are 
available as MP3 fi les on the College Historical 
Society website at www.thehist.com.  Go to 
Michaelmas Debates, Select Oct 3: Cannabis, 
then select Recordings.
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The Irish Drug Treatment Court – 
a view from the bench
A European conference on quasi-coerced treatment 
and other alternatives to imprisonment, organised 
by the Council of Europe Pompidou Group and the 
Romanian National Anti-Drug Agency, took place in 
Bucharest, Romania, on 11–12 October. Below is an 
edited version of the presentation made by Judge 
Bridget Reilly of the Irish Drug Treatment Court 
(DTC).
Judge Reilly was appointed to the DTC in 2001. 
Introducing her paper, she said: ‘I have viewed 
the awful cycle of drug abuse – offending – 
imprisonment – release – drug abuse – offending 
– imprisonment, and was struck with a realisation 
of the hopelessness and ineffectiveness of the 
situation. The cycle is self-perpetuating and in 
turn infl uences a wider pool, a new generation, 
increasingly in larger numbers and with more and 
more associated and serious violence. It seemed 
obvious that imprisonment failed to break the 
cycle or to act as a deterrent to further offending. 
Ultimately the interests of the public at large are 
not met and trust in, and collaboration with, the 
criminal justice system is undermined.’
Background
The DTC, established as a permanent court in 2006 
after a fi ve-year pilot phase, deals with offenders 
who have either pleaded guilty or been convicted 
of minor crimes committed as a consequence of 
drug abuse. Referral to the DTC is with the consent 
of the defendant and may be made at the request 
of the defence or a probation offi cer, or at the 
discretion of the presiding judge. At present, such 
offenders must have resided for a minimum of six 
months in the Dublin North Inner City area, an area 
which has suffered a particularly severe drug abuse 
problem.
The primary aim and purpose of the court is ‘the 
reduction of crime through rehabilitation of the 
offender but not excluding punishment should 
the circumstances so warrant’.1 The DTC is a 
full criminal court, but operates differently from 
any other court in that the offender is obliged to 
comply with terms of a programme tailored to his 
or her requirements and circumstances. A multi-
agency team, monitored regularly by the judge, 
and comprising a court co-ordinator, probation 
offi cer, Garda offi cer, clinical health nurse and an 
education offi cer, delivers this programme. Unlike 
many other jurisdictions, the Irish DTC includes an 
education element in the rehabilitation process.
The role of the judge in the DTC
The experience of drug courts internationally has 
highlighted the role of the judge in the whole 
process. In the DTC the judge monitors the 
progress of the participants on the programme and 
provides leadership, motivation and enforcement 
and imposes sanctions. The team meets with the 
defendant at a pre-court meeting. In the early 
stages of the programme the defendant appears 
in court every week but this is reduced as s/he 
progresses through three separate phases. At the 
hearing in open court there is direct dialogue 
between the offender and the bench. The 
participant often volunteers a written submission 
to explain his/her position. Over time a full picture 
of the participant becomes apparent to the court. 
Through continued interaction between judge 
and participant, a relationship develops and it is 
important that the participants appear regularly in 
front of the same judge. However a judge cannot 
sit for 52 weeks of the year and so the President 
of the District Court has appointed two other 
judges to sit in the DTC. In this way the essential 
consistency and continuation of judicial input 
should be maintained and the energy, interest and 
skill of these judges can help in the development of 
all aspects of the court’s work.
Sanctions and incentives
Following the pre-court meeting and appearance 
in open court the Court proceeds to make its order. 
The court uses a ’carrot and stick‘ approach to 
encourage and reward progress, compliance and 
engagement with the programme and to sanction 
failure to comply. The ultimate sanction, and one 
of last resort, is an order terminating the offender’s 
participation on the programme. A number of 
lesser sanctions are also available to the judge. 
The judge has to draw a balance between support, 
encouragement and sanctions. This will depend on 
the character, personality, ability and endeavours 
of the participant and, indeed, on his/her mood 
or vulnerability. My own experience accords with 
research fi ndings which suggest that verbal praise 
is the most valuable currency. One must always 
be aware too that other participants present are 
watching and learning how the system works. They 
are also assessing how others are being treated so 
that the system must be, and must be perceived to 
be, enforced properly and fairly. 
Assessing outcomes
Participants graduate when, at the end of Phase 3, 
they are drug free, have not re-offended and have 
complied with the obligations of each phase of 
the programme. At that time, all charges against 
them are struck out, with liberty to re-enter within 
12 months if there are any breaches of ongoing 
obligations as set out in their life plan prepared for 
graduation. 
It should be noted that all but one of the 88 
charges shown in Table 1 were incurred in the 
initial phase of the three-phase programme. Despite 
the low graduation numbers, the progress and 
improvement in quality of life for the participants 
is seen to be very signifi cant by the DTC team, 
considering the background of low literacy skills, 
low educational participation, and often diffi cult 
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Irish drug treatment court (continued)
social and family history. The court is considering 
an alternative grading process so as to validate the 
success or quasi-success of participants who do not 
attain full graduation criteria, while being aware of 
how this could affect the motivation of participants 
to graduate fully.
A personal observation
In Ireland the background of judges does not 
prepare them fully for dealing with the new process 
in this different court. One must tread very carefully 
and sensitively in pursuing the role of judge in 
this different environment. This new departure 
for me has been challenging and fulfi lling. One 
needs large measures of optimism and a real and 
continuing interest in people, especially on days 
when the reports before the court hearing are bleak 
and disappointing. On the days where progress 
is apparent there is real satisfaction. In particular 
when we have our graduation ceremonies, 
there is joy and hope together with pride for the 
participants and their families at the hard-won 
achievements. They truly deserve the respect and 
admiration they earn. 
Conclusion
The Drug Treatment Court is to be expanded and 
enlarged and we look forward to this development 
sooner rather than later. The DTC can only ever 
be part of a strategy to reduce crime. It cannot 
eliminate the need for prison or other forms of 
restraint entirely, particularly in relation to certain 
crimes of a very serious nature. 
(Edited by Johnny Connolly) 
1. Irish Courts Service (1999) First Report of 
the Drug Court Planning Committee. Dublin: 
Stationery Offi ce.
A manual in quality standards in substance use 
education was launched on 10 September 2007. 
The manual was produced by members of the Drug 
Education Workers Forum (DEWF), a voluntary 
organisation committed to identifying and 
responding to the needs of voluntary, community 
and statutory drug education workers in Ireland. 
DEWF has identifi ed a need for ‘clear, practical 
information on best practice in substance use 
education in Ireland.’1
The aim of the manual is to provide a clear 
framework for practitioners of substance use 
education, such as workers in drug education and 
community education or development, youth 
workers, and health promotion staff, and for 
individuals and agencies commissioning substance 
use education, such as youth work management 
boards, school boards of management and 
principals, and community education organisations.
The manual was compiled by DEWF members 
who work in substance use education. It should 
be noted that it is not aimed at primary or post-
primary teachers, who already have guidelines and 
resources in the Walk Tall and SPHE programmes. 
The manual is based on a substantial review 
of international research and best practice and 
provides guidelines for the development and 
enhancement of substance use education in school, 
youth-work, and community-based settings. 
Three working groups were set up, each designed 
to address the needs of one of these settings. 
Members of the working groups had experience 
and expertise in those settings and came from the 
community, voluntary and statutory sectors. Other 
individuals and agencies were invited to contribute 
their expertise, and a series of focus groups was 
held with programme participants and substance 
use education providers. 
These standards will greatly enhance good 
practice and quality in this critical prevention/ 
education pillar of the National Drugs Strategy. 
It certainly represents a concrete example 
of collective refl ection, peer support and 
professional development that members of 
Quality standards in substance 
use education
(L to r) Deputy Lord Mayor of Dublin, Cllr. 
Anne Carter, Feidhlim O Seasnáin, chair of 
DEWF, and Patricia O’Connor, director of the 
National Drugs Strategy Team, at the launch 
of the DEWF standards manual.  
Total charges incurred prior to referral to 
the DTC
518
Total charges incurred during the DTC 
programme 88
Source: An Garda Síochána, March 2005
Table 1 Criminal charges incurred by participants 
in the DTC in March 2005
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In the autumn of 2007 The National 
Documentation Centre (NDC) took a survey of 
registered users of the NDC website to gather 
feedback on their experiences of using the site. The 
survey sought to fi nd out:
Who is using the NDC website, and what type  ■
of work they do
How they learned about the site ■
What their purpose was in coming to the site ■
Whether they fi nd it easy to navigate the site  ■
and fi nd the information they need
Whether they have any diffi culties in using the  ■
site
Which parts of the site they use most frequently ■
What they think of the quantity, quality and  ■
usefulness of the information on the site
What improvements or additional resources/ ■
services they might like to see on the site.
We sent a questionnaire by email to 1,222 
registered users of the NDC, and received 288 
replies – a response rate of 23.56%. We used SPSS 
to analyse the data. 
Key survey fi ndings
One-fi fth (20.3%) of the respondents work in a  ■
university or college environment, and 14.7% 
described themselves as researchers.
A majority (more than 75% in each case) rated  ■
the site as ‘Good’ or ‘Excellent’ in terms of 
ease of use, design and layout, and quality and 
quantity of information (see Table 1). 
In relation to the resources currently available  ■
on the website, 77.4% (n=223) of respondents 
said that they were very interested in the 
Alcohol and Drug Research Unit publications, 
while 68.1% (n=196) said they were very 
interested in the annual national report on drug 
use in Ireland (see Table 2).
18.7% (n=53) of respondents heard about the  ■
NDC website from a colleague, and the same 
number, 18.7% (n=53), heard about us through 
an educational institution.
the Forum have been engaged in since its 
formation. (Finbar O’Brien, NDST chair)
The manual is highly structured and provides a 
consistent framework of standards across the three 
education settings. Elements common to the school 
and youth-work settings include substance use 
policy, managing incidents, and staff development. 
Elements in the community-based setting include: 
education with drug service users, Travellers, and 
parents and guardians.
The manual also includes a ‘core skills and 
competencies’ audit for practitioners at three levels: 
foundation level, including core knowledge, • 
attitudes and skills;
generalist competences, including • 
substance use education and prevention 
work, targeted education, advice giving, 
programme deliver etc.;
specialist competencies.• 
DEWF is developing a training schedule to 
accompany the manual. It is envisioned that a two-
day ‘training of trainers’ programme will be offered 
by members of the DEWF working groups. This will 
enable trainers to offer in their own regions a one-
day training programme on use of the manual. 
DEWF has emphasised the evaluation component 
of the manual. It is hoped that users will become 
involved in an evaluation process, to enable further 
development and enhancement of the standards 
over time.
The production of the manual was funded under 
the National Drugs Strategy. Further information 
can be found on the DEWF website www.dewf.ie.
It is important to remember that everyone 
in society has a role to play in imparting and 
supporting substance use education and 
prevention messages. Substance use education 
belongs in schools, families, work places and 
other environments; it can contribute to the 
achievement of broader public health goals of 
preventing and reducing drug related harm 
for both the individual and society. (Feidhlim O 
Seasnáin, DEWF chair)
(Louise Farragher)
1. Butler E, Keane R, Rowley C, Smith S (2007) 
A manual in quality standards in substance use 
education. Dublin: Drug Education Workers 
Forum.
Quality standards manual (continued)
The NDC website: results of user 
survey 
Answer options Excellent Good
Ease of using the site 30.2% 56.3%
Overall design/look 17.4% 60.1%
Quality of content 48.6% 42.7%
Quantity of content 34.7% 50.7%
Table 1   Satisfaction with NDC website
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47.7% (n=135) said their main reason for using the  ■
site was work related, and 29.7% (n=84) said it was for 
research purposes.
37.1% (n=105) visit the site on a monthly basis and  ■
28.6% (n=81) visit on a daily or weekly basis.
Views/comments
Almost all comments were complimentary of the resources 
and services available through the website. We will use all 
comments and suggestions to inform further development 
and improvement of the site. We are compiling a response to 
users’ queries and will post it on the site in the near future. 
Our thanks to everyone who took part in this survey. 
(Mairea Nelson)
NDC website user survey (continued)
Students from the Trinity Diploma in Addiction Studies on a visit to the NDC
Answer options Very interested Interested
Alcohol and Drug Research Unit publications 77.4% 17.0%
Annual national report on drug use in Ireland 68.1% 19.8%
Current Research and Evaluation Database (CRED) 44.1% 32.6%
Directory of researchers and evaluators 20.8% 31.6%
Directory of training courses 34.0% 28.8%
E-Drugnet Ireland 43.1% 33.0%
Library services 
(document-supply service, provision of full text documents, reference service etc.) 60.1% 22.9%
Links page 33.0% 42.7%
NDC Database 44.1% 34.4%
NDC Newsletter 42.0% 30.6%
News page 42.4% 32.3%
Policy documents 46.2% 31.6%
Research tools 38.9% 34.4%
Thesis page 28.1% 31.6%
Table 2   Interest in services / resources available on the NDC website
drugnet 
IRELAND
26
In brief
On 2 May 2007 the National Crime Council (NCC) 
published the report Problem-solving justice – the case 
for community courts in Ireland. It recommends the 
establishment of community courts, starting with inner-
city Dublin. Community courts are being developed in 
other jurisdictions as an example of ‘problem-solving 
justice’ to deal with less grave crimes which have a 
material impact on the ‘quality of life’ of citizens, such 
as drug possession, public order offences, petty theft, 
prostitution or vandalism. www.gov.ie/crimecouncil/ 
In June 2007 the Parole Board published its annual 
report for 2006. The chair of the Board observed, ‘It is a 
matter of grave concern to the Board that drugs appear 
to be available in many of the prisons and places of 
detention in the country. ... In considering whether 
or not to recommend temporary release (commonly 
known as parole) in any given case to the Minister, the 
Board’s prime concern is the danger that the prisoner 
will re-offend. Quite clearly, if that prisoner is still on 
drugs, the risk of his or her re-offending is increased 
immeasurably. It is virtually impossible to see how the 
Board could recommend temporary release in respect 
of a prisoner who still requires to feed a drug addiction.’ 
www.justice.ie 
On 10 September 2007 Teenspace: National Recreation 
Policy for Young People was launched by the Minister 
for Children, Brendan Smith TD. The policy states that 
sport, recreation and leisure activities are effective in 
preventing young people from using alcohol and drugs. 
However, it recognises that at-risk youth – early school-
leavers, socially excluded young people, Travellers – 
may lack positive motivation to participate and that this 
step must be made fi rst. The policy also acknowledges 
the need for alcohol- and drug-free spaces for young 
people. www.omc.gov.ie 
On 20 September 2007 the EAP Institute hosted its 
28th annual conference, ‘Drugs & Alcohol at Work 
– Complying with the Safety Health & Welfare 
at Work Act 2005’. The conference heard that 
policies and procedures for handling situations where 
employees report for work while under the infl uence 
of alcohol and/or drugs should now be in place in all 
organisations, and that incidents of this nature should 
now be considered gross misconduct. www.eapinstitute.
com 
On 30 September 2007 the Maritime Analysis and 
Operations Centre (Narcotics) (MAOC-N) was 
established, when a treaty was signed by Ireland, the 
UK, the Netherlands, France, Spain, Portugal and Italy. 
Based in Lisbon, the MAOC-N is an international task 
force that will collect and analyse information on drug 
traffi cking, enhance intelligence exchange and identify 
the availability of naval and other assets to facilitate 
national drug interdiction operations. It will focus 
on interdicting large maritime and aviation cocaine 
shipments, especially from South and Latin America. 
www.justice.ie 
In September 2007 the Dublin North-East Drugs Task 
Force launched issue 1 of Uth. www.dnedrugstf.ie 
In September 2007 the Addiction Search Engine 
(ASE) was launched by the Ana Liffey Drug Project. This 
Google-customised search engine is designed to help 
users fi nd information about addiction and drug-related 
issues. The ASE searches over 100 specially selected 
websites and the sites that they are linked to. The ASE 
can be accessed via the website of the Ana Liffey Drug 
Project. www.aldp.ie 
On 1 October 2007, World Hepatitis Awareness Day 
(WHAD), the Central and Eastern European Harm 
Reduction Network (CEEHRN) published a study, 
HCV infection in Europe. It highlights the signifi cant 
inconsistencies in HCV testing and diagnosis across 
Europe. Only 10% – 40% of people with HCV know 
about their infection, according to data from different 
parts of Europe. (On 10 October 2007 the Eurasian 
Harm Reduction Network (EHRN) was adopted as 
the new name of the CEEHRN, to more accurately 
refl ect the geographic scope of the network throughout 
Central and Eastern Europe and Central Asia.) www.
ceehrn.org 
On 10 October 2007 the Council of Europe’s 
Committee for the Prevention of Torture (CPT) 
published a report on its 4th periodic visit to Ireland, 
which took place in October 2006, together with the 
response of the Irish government. The report stated that 
there was an increasing level of inter-prisoner violence, 
fuelled by the widespread availability of illicit drugs and 
the existence of a gang culture. www.cpt.coe.int/
On 18 October 2007 Business in the Community 
Ireland (BITCI) launched its landmark report on best 
practice in corporate responsibility in Ireland in 2006. 
Among the case studies described was Oracle Emea 
Ltd, which encouraged its employees to volunteer in 
their local community. Over 100 Oracle volunteers 
participated in projects, including the painting of the 
Chrysalis Community Drug Project. www.bitc.ie 
On 23–24 October 2007 the Children Acts Advisory 
Board (CAAB) held its national conference, ‘Sharing 
the Task: Achieving Child Protection & Welfare through 
Interagency-Working’, in Kilkenny. The CAAB is the 
new name for the Special Residential Services Board 
(SRSB), whose name and functions were changed in 
the Child Care (Amendment) Act 2007. The CAAB has 
broader functions, becoming an overall advisory body 
whose functions now include providing advice to the 
Minister for Children on policy issues relating to the co-
ordinated delivery (and effectiveness) of services to at 
risk children/young people specifi cally under the Child 
Care Act 1991 and the Children Act 2001. www.caab.ie 
In October 2007 the International Drug Policy 
Consortium (IDPC) published the fi rst iteration of its 
Advocacy Guide. In the run-up to the forthcoming UN 
review of its drug strategies since 1998, this advocacy 
guide serves as an introduction to the structure 
and operation of the UN drug control systems, and 
describes the review processes that will take place 
throughout 2008, culminating in a high-level political 
meeting in 2009. As the review process progresses, 
updated versions of the IDPC Advocacy Guide will be 
released in order to update civil society and refi ne the 
IDPC position. www.idpc.info 
(Compiled by Brigid Pike)
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EMCDDA releases 2007 Annual report
Cited from Drugnet Europe No. 60, October-December 2007, 
p.1 
‘After over a decade of rising drug use, Europe may now be 
entering a more stable phase. Not only are there signs that 
heroin use and drug injecting have become generally less 
common, but new data suggest that levels of cannabis use 
may now be stabilising after a sustained period of growth. 
Nevertheless, positive messages are marred by high levels of 
drug-related deaths and rising cocaine use.’ These were the 
key points stressed by the EMCDDA as it launched its 2007 
Annual report on the state of the drugs problem in Europe 
on 22 November in Brussels.
EMCCDA Director Wolfgang Götz highlighted in particular 
that drug use has stabilised in a number of important areas, 
albeit at historically high levels. In some cases, there are even 
signs that merit cautious optimism – such as relatively stable 
levels of heroin and cannabis use and mostly low rates of 
HIV transmission among drug injectors. There had also been 
a dramatic increase in countries’ investment in prevention, 
treatment and harm-reduction activities and improved focus 
and cooperation in supply reduction. Furthermore, the EU is 
backing global actions to reduce drug problems by funding 
supply and demand reduction measures in third countries to 
the tune of at least €750 million.
HIV: overall positive assessment
Cited from Drugnet Europe No. 60, October–December 2007, 
p.8
The rate of HIV transmission among injecting drug users 
(IDUs) was low in most EU countries in 2005. This positive 
picture can be seen in the context of greater availability of 
prevention, treatment and harm- reduction measures and 
declining popularity of drug injecting in some countries. 
With the expansion of services, the HIV epidemics seen 
earlier in Europe seem largely to have been avoided. 
According to the Annual report: ‘The situation in Estonia, 
Latvia and Lithuania remains a concern, but here again 
most of the recent data point to a relative decrease in new 
infections’. As a result of lower rates of transmission, the 
overall burden of infection resulting from injecting drug use 
is likely to be falling, especially in areas of high prevalence. 
Although injecting drug use has become less important as 
a route of HIV transmission, the EMCDDA estimates that, 
in 2005, it still accounted for some 3 500 newly diagnosed 
cases of HIV in the EU. This fi gure may be low by historical 
standards, yet it still represents a considerable public health 
problem. The report states that between 100,000 and 
200,000 people who have ever injected drugs are living with 
HIV. The hepatitis C virus (HCV), however, is more prevalent 
among IDUs in the EU than HIV and more evenly distributed. 
The EMCDDA estimates that around 1 million people who 
have ever injected drugs are living with HCV.
The 2007 EMCDDA report is covered in the article ‘2007 
report on the drugs problem in Europe’, on p. 18 of this 
issue.
From Drugnet Europe
No. 17: Cocaine use in Europe: implications for service 
delivery 
Cocaine use presents new challenges for Europe’s drug 
treatment services. Although services can leverage 
experiences gained in responding to other types of drug 
problems, the pharmacology of cocaine, the social diversity 
of users and the concurrent use of other psychoactive 
substances complicate the development and targeting of 
responses. And unlike treatment for opioid users, there 
are no proven effective substitution or pharmacological 
treatment options currently available for cocaine users. 
This paper addresses a number of important issues for the 
delivery of services for cocaine users. How can the different 
groups of users be reached and helped? What type of 
treatment should be made available for dependent cocaine 
users? Are new specialised services needed, or should 
existing ones be adapted?
Key issues at a glance
Some 4.5 million European adults (1.3%) have used 1. 
cocaine in the last year. Last year cocaine prevalence has 
shown an overall upward trend over the last decade, 
although with variations between EU Member States, 
ranging from 0.1% to 3.0% of the population.
Cocaine use can lead to dependence and treatment 2. 
demand related to cocaine has increased. Psychiatric, 
cardiovascular and other health problems are also 
associated with cocaine use. Injecting cocaine carries the 
risk of transmission of blood-borne diseases such as HIV 
and hepatitis C.
Three core groups of problem cocaine users can be 3. 
identifi ed: socially well-integrated individuals; opioid 
users, some of whom are substitution treatment clients; 
and marginalised crack users.
These groups differ in drug use patterns, health and 4. 
living conditions. Their needs range from access to 
information about cocaine-related risks to specifi c 
treatment or harm reduction interventions.
Current responses to cocaine-related problems draw 5. 
largely on existing services targeted at opioid use and 
drug use in recreational settings. These existing services 
may need adapting to meet the specifi c needs of cocaine 
and crack users.
Improvements could include: specifi c cocaine and 6. 
crack strategies; training and research on the treatment 
of cocaine dependence; outreach interventions; and 
tailored treatment services for specifi c groups of cocaine 
and crack users.
Conclusions and policy considerations
Specifi c strategies targeting cocaine or crack cocaine 1. 
use should be developed in areas where the extent of 
the problem, such as in some European countries and 
cities, requires a concerted response. Elsewhere, drug 
policies should address the growing diversity in drug use 
patterns and needs of problem drug users.
Drugs in focus – policy brieﬁ ng
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Prevention and harm reduction approaches related 2. 
to cocaine use need to be developed, in particular 
information on risks (cardiovascular, psychiatric, elevated 
toxicity of some forms of polydrug use). Both occasional 
and regular cocaine users should be targeted.
Interventions to reach and help socially integrated 3. 
problem cocaine users can be developed by adapting 
existing services or, in some cases, providing dedicated 
treatment services.
Crack users, and other marginalised populations of drug 4. 
users, should have access to harm reduction outreach 
interventions including service referral.
In all treatment settings, training in psychosocial 5. 
interventions should have high priority as this kind of 
intervention has shown the best results. Exchanging 
knowledge and best practice among clinicians and other 
drug workers should be encouraged.
Research on psychosocial interventions and on new 6. 
pharmaceutical agents to treat cocaine-dependent 
clients should be promoted. There is also an urgent need 
to better understand polydrug use involving cocaine, its 
multiple variants and consequences.
Drugnet Europe is the quarterly newsletter of 
the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA). Drugs in 
focus is a series of policy briefi ngs published 
by the EMCDDA. Both publications are 
available at www.emcdda.europa.eu.
If you would like a hard copy of the current 
or future issues of either publication, please 
contact: 
Alcohol and Drug Research Unit, 
Health Research Board, 
Knockmaun House, 
42–47 Lower Mount Street, 
Dublin 2. 
Tel: 01 2345 127 
Email: adru@hrb.ie.
Drugs in focus (continued)
Books
What’s wrong with addiction?
Keane H
Melbourne University Press 2002, 228 pp.
ISBN 0 522 84991 1
This book takes the view that, while there is a pervasive 
theme of addiction as a disorder marked by physical, psychic 
and moral pathology, the ‘wrongness’ of addiction is not 
fi xed nor indeed obvious. It varies according to context: 
the type of addiction and the type of addicted body, and 
the type of discourse. The author presents the argument 
that many of the harms, both individual and social, that 
are associated with addiction are secondary consequences, 
rather than essential and inevitable elements of the 
addictive experience. She examines why it is bad to be an 
addict and what the wrongness of addiction is, focusing 
on how the problems and experiences we group under 
the term addiction are wrong. The book exposes strains 
in contemporary oppositions between health and disease, 
between the natural and the artifi cial, between order and 
disorder and between self and other.
Chapter 1 discusses pharmacological understandings of 
drugs and neurological models of addiction. Chapter 2 
explores the substance dependence syndrome of medical 
discourse and the problems of diagnosing dependence as 
a medical disorder. Chapter 3 deals with popular addiction 
discourse and its engagement with issues of selfhood. 
Chapters 4, 5 and 6 apply the concept of addiction to 
substances and behaviours other than drugs or alcohol – 
smoking, food and sex. Chapter 7 questions the promise of 
happiness and health to be found in the ‘utopia of recovery’ 
as presented in popular addiction discourse.
The fi nal chapter summarises the argument developed in the 
book, suggesting that the expansion of addiction discourses 
should be resisted or at least questioned. The author argues 
that the development of new and wide-ranging addictive 
pathologies cannot help but strengthen the hold of medical 
expertise and therapeutic authority over people’s conduct 
and desires. In her view, the growth of addiction demands 
scrutiny because it is a notion through which specifi cally 
liberal forms of political power and government regulation 
operate effi ciently and seductively.
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Recent publications (continued)
Anti-drugs policies of the European Union: 
transnational decision-making and the politics of 
expertise
Elvins M
Palgrave Macmillan 2003, 227 pp.
ISBN 0 333 98213 4
This book traces the evolution of enforcement-
based anti-drugs policies at EU level from the 
late 1960s to the present. It considers their 
development in the contexts of European 
integration and the broad harmonisation of 
international policies against drug traffi cking. The 
author examines the underlying logic of the policy 
process, and assesses the infl uence of drug issues 
on the emergence of wide-ranging EU security 
institutions such as Europol. He states that the 
primary rationale employed by policy makers is 
based on some notion of protection: from the 
impact of drugs on public health, from crime 
associated with drug use, and from the use of 
violence and corruption by traffi ckers. He goes on 
to argue that this shared rationale has led to a clear 
convergence in drug-traffi cking policies adopted 
by states across the world. By way of contrast, 
and in spite of recent UN efforts, there is no 
international consensus on the appropriate form, 
mix or effi cacy of ‘positive control’ measures – 
particularly those aimed at reducing consumption, 
from education to harm-reduction techniques 
such as needle-exchange programmes – hence the 
right of initiative is left primarily in the hands of 
national (and to a large extent regional and local) 
authorities.
The author assesses the infl uence of transnational 
networks of expertise on policy development, 
and explores questions about the changing 
nature of state power and state sovereignty 
under globalisation. He examines the practices of 
contemporary European governance and raises 
concerns about secretive and anti-democratic 
features of inter-governmental EU decision making. 
The wider contention of the book is that the key 
to understanding contemporary state power in 
the area under discussion lies in understanding 
the policy-making actors whose control over 
knowledge is vital in providing the rationale for 
policy and in creating and sustaining a normative 
framework through which policy decisions are 
fi ltered by the political decision makers of national 
states. The book assesses the extent to which a 
pseudo-scientifi c ‘technical’ approach has become 
the dominant means through which policy 
‘solutions’ for complex transnational problems 
(such as drug traffi cking) are mediated. 
Child protection, domestic violence and parental 
substance misuse
Cleaver H, Nicholson D, Tarr S and Cleaver D
Jessica Kingsley Publishers 2007, 232 pp.
ISBN 978 1 84310 5824 
This book is based on a two-year study 
commissioned under the UK government’s Quality 
Protects research initiative. The study examined 
how one of the objectives of that initiative, 
Protection from Signifi cant Harms, is working for 
children and young people referred to care services. 
In reporting on this study, the book focuses on 
how child protection practices and procedures 
respond to children and families affected by 
domestic violence and/or parental substance 
misuse. It reveals the vulnerability of children 
in such situations and the negative impact on 
their health and development, on the adults’ 
capacity to undertake key parenting tasks, and on 
family functioning, housing, income and social 
integration. The book describes the extent to 
which services work together in such cases and 
identifi es factors that support collaborative working. 
It includes parents’ own voices and allows them 
to explain what help they feel would best support 
families in similar situations. The authors also 
explore the response of children’s services, and 
the extent to which current local authority plans 
procedures, joint protocols and training effectively 
support information sharing and collaborative 
working. From the fi ndings, they draw implications 
for policy and practice in both children and 
adult services. This book will be of interest to 
professionals working to promote the welfare and 
well-being of children and those working with 
vulnerable adults and parents.
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Journal articles
The following abstracts are cited from recently published 
articles relating to the drugs situation in Ireland.
Using environmental analytical data to estimate levels 
of community consumption of illicit drugs and abused 
pharmaceuticals 
Bones J, Thomas KV and Paull B 
Journal of Environmental Monitoring 2007; 9(7): 701–707
A solid phase extraction (SPE) method was developed and 
applied in conjunction with a previously reported liquid 
chromatography tandem mass spectrometry procedure in 
order to establish the presence of illicit drugs and abused 
pharmaceuticals in treated wastewater and surface water 
samples at the ng L–1 level. The procedure was applied in 
Dublin, Ireland, and rapidly expanding commuter towns 
in the surrounding counties. Cocaine was detected in 70% 
of the collected samples in the range of 25–489 ng L–1; 
its primary metabolite, benzoylecognine (BZE), was also 
detected, in the range of 22–290 ng L–1. Other substances 
detected included morphine, Tempazepam and the primary 
metabolite of methadone. 
Health care professionals’ knowledge and attitudes regarding 
substance use and substance users 
Kelleher S 
Accident and Emergency Nursing 2007; 15(3): 161–165
In Ireland one in four (28%) of those attending hospital 
emergency departments have substance-abuse-related 
injury/illness and one in eight (13%) present in a state of 
clinical intoxication. Health care professionals working in 
emergency departments are frequently exposed to patients 
with substance use problems and are in ideal positions 
to provide early diagnosis and treatment. The success 
rate in detecting these patients is, however, disturbingly 
low (25–50%) and many substance-use problems are 
misdiagnosed or remain undetected. International studies 
that focus on primary care and addiction within the 
mental health sector suggest that health care professionals’ 
knowledge and attitudes regarding substance use and 
substance users may negatively infl uence the care that these 
patients receive. There is a dearth of empirical research 
on this issue, internationally and in Ireland, particularly in 
emergency department settings.
Heroin epidemics, treatment and ODE modelling 
White E and Comiskey C 
Mathematical Biosciences 2007; 208(1): 312–324
The UN, EU and World Health Organization (WHO) have 
consistently highlighted in recent years the ongoing and 
persistent nature of opiate, particularly heroin, use on a 
global scale. Authors have emphasised the signifi cant impact 
such an epidemic has on individual lives and on society. 
National prevalence studies have indicated the scale of the 
problem, but the drug-using career, typically consisting 
of initiation, habitual use, a treatment–relapse cycle and 
eventual recovery, is not well understood. This paper 
presents one of the fi rst ODE models of opiate addiction, 
based on the principles of mathematical epidemiology. The 
aim of this model is to identify parameters of interest for 
further study, with a view to informing and assisting policy-
makers in targeting prevention and treatment resources for 
maximum effectiveness. An epidemic threshold value, R0, 
is proposed for the drug-using career. Sensitivity analysis 
is performed on R0 and it is then used to examine the 
stability of the system. A condition under which a backward 
bifurcation may exist is found, as are conditions that permit 
the existence of one or more endemic equilibria. A key result 
arising from this model is that prevention is indeed better 
than cure.
Hospital admission for acute pancreatitis in the Irish 
population, 1997–2004: could the increase be due to an 
increase in alcohol-related pancreatitis?
O’Farrell A, Allwright S, Toomey D, Bedford D and Conlon K 
Journal of Public Health 2007; 29(4):398–404
The objective of this research was to investigate trends in 
the incidence of acute pancreatitis by examining emergency 
admissions to acute public hospitals over an eight-year 
period; to compare trends for alcohol-related pancreatitis 
admissions with admissions related to biliary tract disease; 
and to profi le the patients admitted with an acute 
pancreatitis diagnosis.
All in-patient emergency admissions for which acute 
pancreatitis (ICD-9-CM Code 577.0) was recorded as 
principal diagnosis were identifi ed for years 1997–2004 
inclusive. Alcohol-related acute pancreatitis admissions (with 
alcohol misuse recorded as co-morbidity) were identifi ed 
using ICD-9-CM-codes 303 and 305. Admissions with biliary 
tract disease recorded as co-morbidity were identifi ed using 
ICD-9-CM codes 574.0–576.0 inclusive. Pearson’s {chi}2-test 
was used to compare proportions in groups of categorical 
data and {chi}2-tests for trend were used to identify linear 
trends.
There were 6291 emergency admissions with a principal 
diagnosis of acute pancreatitis in the eight-year study period, 
with 622 admissions in 1997 compared to 959 in 2004, an 
increase of 54.1%. Age standardized rates rose signifi cantly 
from 17.5 per 100 000 population in 1997 to 23.6 in 2004 
(P < 0.01 for linear trend). There were 1,205 admissions with 
alcohol misuse recorded as a co-morbidity, increasing from 
13.9% (87/622) of acute pancreatitis admissions in 1997 
to 23.2% (223/959) in 2004. This increase was signifi cantly 
greater than that observed in admissions related to biliary 
tract disease, 19.6% (122/622) in 1997 to 23.5% (225/959) 
in 2004. Rates for total acute pancreatitis admissions were 
highest in those aged 70 years and over; the majority (3563, 
56.6%) were male, with a mean age of 51.1 years (SD 19.9); 
the mean age for male admissions was signifi cantly younger 
than that for female admissions (49.1 versus 53.6 years, P < 
0.001). However, for alcohol-related admissions, rates were 
highest in those aged 30–49 years, and patients admitted 
with alcohol misuse recorded were signifi cantly younger 
than those who did not have alcohol misuse recorded 
(42.0 versus 53.2 years, P < 0.001). Median length of stay 
was seven days. The increasing trend in alcohol-related 
acute pancreatitis parallels the rise in per capita alcohol 
consumption. Given the continuing rise in binge drinking, 
particularly among young people, this is a cause for concern.
(Compiled by Joan Moore and Louise Farragher)
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(Compiled by Louise Farragher – lfarragher@hrb.ie)
January
31 January 2008
The First National Service User Involvement 
Conference: Nothing About Us Without Us!
Venue: Birmingham
Organised by / Contact: Drink and Drug News
Tel: +44 (0)20 7463 2081
Email: info@cjwellings.com 
www.drinkanddrugs.net
Information: This fi rst national service user 
involvement conference will bring together 
policymakers, service user co-ordinators from drug 
action teams, and drug and alcohol service users 
from all over the UK. The event is organised by 
Drink and Drugs News magazine (the fortnightly 
magazine for the drug and alcohol fi eld) in 
partnership with The Alliance, the organisation that 
provides advocacy and training to people involved 
in drug treatment. The purpose of this event is 
to construct a meaningful dialogue and a shared 
agenda around service user involvement, during 
the transition period of a new drug strategy. We 
will demonstrate that service users’ involvement is 
crucial to shaping drug treatment and policy of the 
future, and help those who work with service users 
to do their job more effectively. The day’s events 
will help to defi ne the way forward for service user 
involvement in the drug and alcohol fi eld and is 
an essential event for everyone who cares about 
getting it right.
January–March 
Managing the Performance, Safety and Health 
Risks of Employee Drug and Alcohol use
Organised by / Contact: Anita Furlong, EAP 
Institute, 143 Barrack Street, Waterford. 
Tel: +353 (0)51 855733 
Fax: + 353 (0)51 879626
Email: maurice@eapinstitute.com 
www.eapinstitue.com
Thursday 17 January 2008 
Venue: Stillorgan Park Hotel, Dublin
Thursday 21 February 2008 
Venue: Clarion Hotel Suites, Ennis Road, Limerick
Thursday 6 March 2008 
Venue: Radisson Hotel, Little Island, Cork
Information: The Safety, Health and Welfare at 
Work Act 2005 was signed into law in June 2005. 
Included in the Act are new duties on employees as 
follows: 
Not to be under the infl uence of an • 
intoxicant (defi ned as drugs and alcohol) to 
the extent that they endanger their own or 
other persons safety;
Not to report or be in an unfi t condition at • 
their place of work due to the consumption 
of an intoxicant to the extent that they 
endanger their own or another’s safety. An 
employer may remove an employee from 
the workplace who reports for duty in such 
condition. Safety statements should now be 
updated to refl ect this new risk. 
The purpose of this seminar is to outline the 
impact of drug impairment in the workforce and 
practical steps in the recognition and treatment 
of employees whose behaviour presents risks to 
themselves and others while at work.
April
3–4 April 2008
Second International Conference of the 
International Society for the Study of Drug Policy
Venue: Lisbon, Portugal
Organised by / Contact: The International Society 
for the Study of Drug Policy 
www.issdp.org/conferences.htm 
Information: This event is being supported by the 
European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) and the Instituto da Droga 
e da Toxicodependência (IDT). The four themes of 
the conference will be:
Developing drug policy evaluation: where • 
are we? 
Defi ning drug policy models/types • 
The rise of security and public nuisance • 
concerns 
The integrated approach to both licit and • 
illicit drugs: From theory to practice.
May 
11–15 May 2008
International Harm Reduction Association 19th 
International Conference: Towards a global 
approach 
Venue: Palacio de Congresos, Fira de 
Barcelona, Spain
Organised by/ Contact: International Harm 
Reduction Association (IHRA)
Tel: +44 (0) 207 462 6997 
Fax: +44 (0) 207 462 6999
Email: info@ihraconferences.com 
www.ihra.net/Barcelona/Home 
Information: IHRA’s harm reduction conferences 
have been held around the world every year since 
1990, and the next event takes place in Barcelona. 
Upcoming events
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Over fi ve days, this conference will be the 
main meeting point for those interested in 
harm reduction, and an invaluable platform for 
debate, discussion, and the dissemination of 
new and evolving good practice in addressing 
drug use and associated harm. 
29–31 May 2008
EUROPAD 8 Conference
Venue: Kempinski Hotel, Sofi a, Bulgaria
Organised by / Contact: EUROPAD: European 
Opiate Addiction Treatment Association 
www.europad.org 
Information: Further details to be announced. 
July
7–9 July 2008
Beyond 2008 Forum 
Venue: Vienna, Austria
Organised by / Contact: Vienna NGO 
Committee 
Email: www.vngoc.org 
info@vngoc.org
Information: Beyond 2008 is a joint initiative of 
the Vienna and New York NGO Committees on 
drugs to facilitate an effective contribution from 
NGOs to the UNGASS Review. The target date of 
2008 agreed at the 1998 UNGASS on Drugs for 
the achievement of ‘signifi cant and measurable 
results’ presents an opportunity for the NGO 
community to refl ect on its own achievements 
in drug control, exchange ideas on promising 
new approaches, reach agreements on ways to 
work together and make recommendations to 
multilateral agencies and UN member states on 
future directions for drug control. Building on 
past experience, the Vienna NGO Committee 
will host Beyond 2008 to contribute to the 
1998–2008 review and agenda-setting exercise 
being undertaken by the Commission on 
Narcotic Drugs (CND). 
The Alcohol and Drug Research Unit 
(ADRU) of the Health Research Board is 
a multi-disciplinary team of researchers 
and information specialists who provide 
objective, reliable and comparable 
information on the drug situation, its 
consequences and responses in Ireland. 
The ADRU maintains two national drug-
related surveillance systems and is the 
national focal point for the European 
Monitoring Centre for Drugs and Drug 
Addiction. The unit also manages the 
National Documentation Centre on Drug 
Use. 
The ADRU disseminates research fi ndings, 
information and news through its 
quarterly newsletter, Drugnet Ireland, and 
other publications. Through its activities, 
the ADRU aims to inform policy and 
practice in relation to drug use.
Drugnet Ireland mailing list
If you wish to have your name included on 
the mailing list for future issues of Drugnet 
Ireland, please send your contact details to:
Alcohol and Drug Research Unit
Health Research Board
Knockmaun House
42–47 Lower Mount Street
Dublin 2
Tel: 01 2345 127
Email: adru@hrb.ie
Please indicate whether you would also 
like to be included on the mailing list for 
Drugnet Europe or Drugs in focus.
Have your contact details changed?
We want to make sure that our mailing lists contain the correct contact details for all our 
readers.  If there have been any changes to your title, organisation, address (postal or email), 
or telephone number, please let us know so that we can update our records. 
You can contact the Alcohol and Drug Research Unit by telephone at (01) 2345 127, 
or by email at adru@hrb.ie.
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